Trading Analysis Report: KGC¶

Analysis date: 2026-10-14
Rating: Overweight
Generated: 2026-10-14 17:28:41
TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

I. Analyst Team Reports¶

Market Analyst¶

Current Price: 22.24 Price As Of: 2026-10-14

KGC (Kinross Gold Corporation, NYSE): Technical Report as of 2026-10-14¶

1. Data integrity notes¶

No conflicts with the verified snapshot. The price series, RSI (29.20), MACD (-1.38), Bollinger lower band (20.85) and the SuperTrend distances all match the snapshot or recompute correctly from it.
MFI scale. The tool describes MFI as 0–100, but it returns 0.25 for today. I read this as a 0–1 ratio, about 25 on the conventional scale. That fits RSI at 29, but the scale is not verified. Treat the MFI figure as "low, near oversold," not as an exact reading.
Today's volume. The 2026-10-14 volume of 10,366,257 is not rounded to the nearest hundred like the other rows. That may mean the bar is partial or still updating. This is unconfirmed. Treat today's close, low and volume as potentially provisional.
DI lines not pulled. I did not pull +DI/-DI. Trend direction below comes from price, the moving averages and SuperTrend, not from the DI lines.

2. Indicators selected and why¶

The set has one or two indicators per category and avoids redundancy. For example, I used RSI and skipped StochRSI. - SuperTrend (weekly/monthly/daily) and ADX: trend direction, trailing-stop levels and trend strength. - Moving averages (10 EMA, 50 SMA, 200 SMA): taken from the verified snapshot for structure. - RSI and MACD: momentum and its rate of change. - Bollinger lower band and ATR: volatility, stretch and risk sizing. - MFI: volume-weighted buying and selling pressure. - TD-9 and Z-score: exhaustion and mean-reversion stretch across three timeframes.

3. Price action context (from the 252 daily bars)¶

Year-long arc. KGC rose from about 25 in mid-October 2025 to a closing high of 37.92 on 2026-01-28. The intraday high was 38.96 on 2026-01-26.
Lower highs since. Later swing closes were 36.84 (2026-02-27), 34.84 (2026-04-17), 33.48 (2026-08-25) and 31.59 (2026-09-03).
Lower lows. Swing-low closes were 26.47 (2026-03-20), 23.63 (2026-06-10), 22.50 (2026-07-20) and now 22.24.
Drawdown. The close is about 41% below the 2026-01-28 close (22.24 vs 37.92).
August rally erased. The stock rose from 23.57 (2026-08-04) to 33.48 (2026-08-25). It has since given back all of that move.
Breakdown on 2026-09-24. Price fell from 27.62 to 24.42 (about -11.6%) on 19.7M shares. That is the heaviest volume since 2026-01-30 (24.97M). This was the decisive break.
Today (2026-10-14).
It gapped down from a 23.44 prior close to a 22.78 open.
The low was 21.90 and the close was 22.24, about -5.1% on the day.
The close sits in the lower third of the day's 21.90–22.86 range (roughly 35% up from the low).
The close is the lowest in the 252-bar window. It is below the 22.50 close of 2026-07-20 and the 22.38 close of 2025-11-04.
The 21.90 low is also marginally below the window's prior lowest low of 21.92 (2025-10-22).

4. Trend: bearish on every timeframe¶

Moving-average stack (snapshot):

Level	Value	Close relative to it
10 EMA	23.63	about 5.9% below
50 SMA	27.59	about 19.4% below
200 SMA	29.20	about 23.8% below

The order is price < 10 EMA < 50 SMA < 200 SMA, a fully bearish alignment. The 50 SMA is below the 200 SMA. I have no data on when that cross happened, so I make no claim about it.

SuperTrend (14, 3×ATR), all three tiers DOWN: - Weekly (primary): stop at 31.25, close 28.84% below it. - Monthly (regime): stop at 37.01, close 39.91% below it. - Daily (entry timing): stop at 25.27, close 11.99% below it. - There is no timeframe conflict. A daily flip would need a close above 25.27, about 3.2 ATR away. A weekly flip would need a close above 31.25.

ADX is 36.83, so this is a strong, established trend. - It was about 4–5 from 2026-09-18 to 2026-09-23. It then jumped to 12.7 on 2026-09-24 and 39.56 on 2026-10-08. - The latest value is 36.83, up from 34.64 on 2026-10-13. The 2026-09-24 gap-down drove the jump. - ADX above 25 means trend-following signals are valid. It says nothing about direction, so the direction comes from the stack and SuperTrend above. - The earlier rangebound phase (ADX under 10) ended with a downside resolution.

5. Momentum: oversold but not yet turning¶

RSI is 29.20, below 30 and the lowest reading in the 30-day lookback.
It was 49.28 on 2026-09-22 and 32.34 on 2026-09-24. It then ranged roughly 31–36 until today's drop.
Today's reading is lower than the 31.13 of 2026-10-07 while price made a lower close. So RSI shows no bullish divergence.
MACD is -1.38, signal -1.28, histogram -0.10.
The MACD line crossed below zero around 2026-09-21/22. It fell to -1.43 by 2026-10-08.
It then stabilized between about -1.33 and -1.43, with the histogram near zero. Selling momentum plateaued before today's decline, and the line is again drifting lower.
MACD (-1.38) is slightly above its 2026-10-08 trough (-1.43) while price is lower (22.24 vs 23.34). That is a marginal, unconfirmed divergence. There is no bullish crossover yet.
MFI is about 0.25 (about 25 if on a 0–100 scale).
It fell from about 0.40–0.47 (2026-09-21 and 2026-09-22) to about 0.26 on 2026-09-24. It has stayed in a roughly 0.17–0.27 band since.
Its troughs were 0.17 on 2026-10-01 and 2026-10-07. The latest 0.25 is above both while price is lower, a mild non-confirmation of the new price low. It shows sellers are active but not accelerating.

6. Volatility and stretch¶

Bollinger Bands: middle 24.88, upper 28.91, lower 20.85.
The lower band has dropped every session since 2026-09-22, from 26.47 to 20.85. The bands have widened and slid lower.
Price (22.24) is 1.39 above the lower band, about 1.4 ATR, and has not closed below the band at any point in the lookback. Position within the bands is about 17%, so it is in the lower portion but not at an extreme.
Closes have stayed below the middle band since 2026-09-24.
ATR is 0.96, about 4.3% of price. Today's high-to-low range (0.96) matched ATR. The gap from the prior close to today's low was 1.54, larger than ATR. Volatility is elevated.
Z-score (20-period): daily -1.31, weekly -1.29, monthly -0.26.
None reaches the |z| ≥ 2 stretch threshold. By this measure price is not statistically stretched, even with RSI below 30.
The decline has been a step-down followed by a grind, so the 20-period mean has fallen with price. This argues against assuming an imminent snap-back.
TD-9 buy-setup counts: weekly +5 of 9, monthly +2, daily +1.
No exhaustion signal is active. The weekly count is the primary tier.
A weekly 9 would need about four more consecutive qualifying weekly bars, so not before roughly mid-November on this count. That is my inference.
The daily +1 means the daily count is just starting. A daily 9 is at least eight sessions away.

7. Key reference levels (from tool output only)¶

Downside: - 21.90: today's low and the window's lowest low. - 21.92: the 2025-10-22 low, which today's low marginally undercut. - 20.85: the Bollinger lower band, a moving target that falls each day. - There is no lower price in the 1-year dataset, so the lower band is the only structural reference below 21.90.

Upside: - 23.44: yesterday's close, where the gap-down began. - 23.63: the 10 EMA. - 24.88: the Bollinger middle band. - 25.27: the daily SuperTrend stop. A close above it flips the daily trend. - 27.59: the 50 SMA, near the 27.62 close of 2026-09-23 before the breakdown. - 29.20: the 200 SMA. - 31.25: the weekly SuperTrend stop.

Historical context, not validated support: - The last time KGC closed in this area (22.54 on 2026-07-17 and 22.50 on 2026-07-20), it later reached 33.48 by 2026-08-25. - It also traded near 22–23 in late October and early November 2025. It then reached 28.23 by 2025-12-01. - Those are facts about past prices, not evidence that this level will hold. - Today's close is below the July low, so any "double-bottom" reading is at risk.

8. Synthesis¶

Bearish evidence: - All three SuperTrend tiers are down. - The moving-average stack is fully bearish. - ADX is above 35. - It is a fresh closing low on a gap-down with elevated volume. - Lower highs and lower lows have run since January. - There are no reversal signals yet. MACD has not crossed up and TD-9 is not near 9.

Counter-trend evidence: - RSI is below 30 and MFI is low. - Price is still 1.4 ATR above the lower band. - The MACD line and MFI have not made new lows with price. - The stock rallied sharply from this region in July–August.

Conflict: The oversold momentum readings clash with the unstretched Z-score, and the trend tools sit above them in weight. Higher tiers dominate (weekly > monthly > daily), and every tier is down. A bounce is possible, but the tools show no confirmed reversal.

Scenarios the data supports: 1. Trend continuation: Failure to reclaim about 23.4–23.6 (the gap origin and the 10 EMA), plus acceptance below 21.90, points toward the lower band near 20.85. ADX above 35 favors this path. 2. Oversold bounce: RSI under 30 and the July–August precedent allow a relief rally. The first hurdles are 23.63, then 24.88 and 25.27. Even a move to 25.27 would only flip the daily trend and leave the weekly and monthly trends down. 3. Trend reversal: This needs a daily close above 25.27, then a MACD bullish cross, and ultimately the weekly stop at 31.25. None of these is close.

Risk sizing: ATR is 0.96, so a 1-ATR move is about 4.3% and a 2-ATR move is about 1.92 points. Daily moves of that size have been common recently: -11.6% on 2026-09-24 and -5.1% today. The 2026-09-24 and 2026-10-14 gaps show that stops can be gapped through.

Caveats: - Today's bar may be provisional. - The MFI scale is ambiguous. - DI lines were not examined. - All levels come from the tool output above.

9. Summary table¶

Category	Indicator	Reading (2026-10-14)	Interpretation
Price	Close / range	22.24; O 22.78, H 22.86, L 21.90; vol 10.37M	Gap down from 23.44, about -5.1%, lowest close in the 252-bar window; bar may be provisional
Trend	10 EMA / 50 SMA / 200 SMA	23.63 / 27.59 / 29.20	Price below all three, bearish stack
Trend	SuperTrend weekly	DOWN, stop 31.25 (-28.84%)	Primary trend bearish
Trend	SuperTrend monthly	DOWN, stop 37.01 (-39.91%)	Regime bearish
Trend	SuperTrend daily	DOWN, stop 25.27 (-11.99%)	A close above 25.27 flips the daily trend
Trend strength	ADX	36.83 (peak 39.56 on 10-08)	Strong trend, direction down (DI not pulled)
Momentum	RSI	29.20	Oversold, no bullish divergence
Momentum	MACD / signal / hist	-1.38 / -1.28 / -0.10	Bearish; plateaued since 10-01 but no upward cross
Volume/flow	MFI	about 0.25 (0–1 scale; scale unverified)	Low and near oversold; above its 10-01 and 10-07 troughs while price is lower
Volatility	Bollinger (lower / mid / upper)	20.85 / 24.88 / 28.91	Price about 1.4 ATR above the lower band; bands falling
Volatility	ATR	0.96 (about 4.3% of price)	Elevated; use for stop distance and size
Stretch	Z-score (D / W / M)	-1.31 / -1.29 / -0.26	Below the ±2 threshold, not statistically stretched
Exhaustion	TD-9 (D / W / M)	+1 / +5 / +2	No signal; weekly 9 is not before about mid-November
Key levels	Downside	21.90, 21.92, 20.85	Today's low, 2025-10-22 low, lower band
Key levels	Upside	23.44, 23.63, 24.88, 25.27, 27.59, 29.20, 31.25	Gap origin, 10 EMA, mid band, daily stop, 50 SMA, 200 SMA, weekly stop
Overall	Tool-supported bias	Bearish trend with oversold momentum	No confirmed reversal yet; a bounce is possible but the trend tools dominate

Sentiment Analyst¶

Overall Sentiment: Mixed (Score: 4.6/10) Confidence: Low

Scope and data limits. Period 2026-10-07 to 2026-10-14 for KGC (Kinross Gold Corporation, NYSE-listed; several headlines reference the TSX:K line). Three sources were specified. Yahoo Finance news gave 4 headlines with no article bodies. StockTwits gave 16 messages. Reddit was skipped by configuration, so r/wallstreetbets, r/stocks and r/investing are entirely silent and no inference is drawn about them. Confidence is low because one source is missing, the news is headline-only, and the StockTwits sample is small and dominated by a few accounts.

1. Source-by-source breakdown

News (4 headlines, event-driven, mildly positive to neutral). (a) UBS cut its price target to $28 from $30 but maintained Buy. This is mixed: a lower target means trimmed estimates or multiple, but the Buy rating is kept. Against the ~$22 price implied by StockTwits posts (the news items give no price), $28 implies roughly 27% upside; this is my inference. (b) Aquitaine Metals closed a C$47M strategic financing with Kinross Gold and Alpayana. This is a mildly positive signal of exploration or optionality, but it is small, and the provided text has no stake size, project or terms. © and (d) Two Simply Wall St. pieces ('Priced Right For Its Earnings Power?' and 'Fresh Update, What Are Investors Weighing Now?') are valuation-framing pieces with no bodies provided, so I treat them as directionally neutral. No headline reports an operational miss, guidance cut or negative corporate event, but four headlines is weak evidence of absence.

StockTwits (16 messages: 7 Bullish / 5 Bearish / 4 unlabeled; 44% / 31% / 25%). At face value this is a mild bullish tilt, but the ratio carries little breadth information because of account concentration. All 5 bearish posts come from one account, @TheLastWiseMan, all on 10/14 between 13:56Z and 17:51Z. They are short and put talk and taunts ('ez short under 22', 'Loading all puts above 23', 'BOOM WE'RE RICH!!!!', 'guess im the only one who made money today'), plus a dismissive swipe at buy-and-hold holders. 6 of the 7 bullish posts come from @Idvst8, spanning 10/7 to 10/14. He reports buying 10k shares at $23.05 on 10/7, expects buybacks to ramp and production to rebound, called the stock 'cheapest from a cash flow perspective' ever, flipped some common on 10/9, and on 10/14 said he is 'adding down here at scale' on a 'final top up'. The 7^th bullish post is @alexx013 ('added 21.93'). So the 12 labeled posts come from just 3 accounts, and the true breadth of retail opinion is not measurable here.

The timeline matters more than the ratio. 10/7 to 10/9 is all bullish dip-buying around $23. 10/13 to 10/14 turns defensive. @Arcides says miners 'basically reversed the whole aug rally' and are 'acting very bad'. @Stocktwits52wLows (an automated-looking account) says KGC printed a new 52-week low on 10/14. I could not verify this independently. @Techdamentals says gold fell more than 1% to about $4,107/oz after a hot inflation report (3.7% vs 3.6% forecast), with the decline driven by rate expectations rather than the print itself. This is also a single unverified post. The two user-reported prices ($23.05 on 10/7 and $21.93 on 10/14) imply a decline of roughly 5% over the week. @greggortrades asked about a '40c 1/28'' option at $1.76. Expiry is ambiguous (possibly Jan 2028), and it hints at long-dated call interest without a stated stance.

Reddit. No data (disabled by config). Nothing can be said about it.

2. Cross-source divergences and alignments - Divergence in the label counts versus price. Bullish labels outnumber bearish, but the tape is weak, with a reported 52-week low and about a 5% weekly decline. The bullish posts are dip-buying and averaging down by one dominant account rather than momentum confirmation. - Divergence between news and tape. Institutional framing is neutral to constructive (Buy maintained, strategic investment, no negative events), while the price and retail tape are deteriorating. The PT cut is the one institutional datapoint that moves in the same direction as the weak tape. - Alignment on the macro driver. Two independent unlabeled posts (@Techdamentals and @Arcides) point to gold weakness and a broad miner selloff as the cause, which is consistent with a sector or macro move rather than a KGC-specific one. This is suggestive only, given the thin evidence. - Asymmetry in argument quality. The bulls cite fundamentals (FCF, buybacks, production rebound), while the bear case is purely price and positioning with no fundamental claims.

3. Dominant narrative themes 1. Gold and rates headwind. A hotter inflation print and higher-for-longer rate expectations pushed gold down more than 1% to about $4,107/oz. 2. Miners giving back gains. The August rally has been reversed and there is a 52-week-low claim. 3. FCF and buyback dip-buying thesis. This is retail opinion, not verified by the supplied data. 4. Production recovery as the hinge. 'Production will rebound' implies production has disappointed. The evidence does not link this to the UBS target cut. 5. Short and put positioning chatter, from a single account. 6. Corporate optionality, shown by the Aquitaine financing.

4. Catalysts and risks Upside catalysts: gold stabilizing or rebounding if rate expectations ease; evidence of a production rebound; buyback acceleration (retail expectation, unconfirmed); a retained UBS Buy with roughly 27% implied upside; small strategic exploration investments such as Aquitaine. The next quarterly results would normally be a fundamental catalyst, but no earnings date is in the provided evidence. Risks: further hot inflation data keeping rates and the dollar supportive and gold pressured; technical breakdown, with a new 52-week low that could trigger stops and momentum selling; follow-on target cuts from other brokers after UBS; a retail thesis that rests on an unconfirmed production rebound; and short and put positioning, although it traces to one account. Missing evidence: no production or guidance data, no earnings date, no verified price or gold series, no article text for the news items, and no Reddit data.

5. Summary table

Signal	Direction	Source	Evidence
UBS PT cut to $28 from $30, Buy kept	Mixed / mildly positive	News (MT Newswires)	Lower target, rating retained; ~27% implied upside vs ~$22 (inferred)
Aquitaine C$47M strategic financing with Kinross and Alpayana	Mildly positive	News (TMX Newsfile)	Strategic investment; no terms in provided text
Simply Wall St. valuation pieces (x2)	Neutral	News	Titles only; no bodies
StockTwits label ratio 7 Bull / 5 Bear / 4 none	Mildly bullish (low quality)	StockTwits	6 of 7 bulls from @Idvst8; all 5 bears from @TheLastWiseMan
Dip-buying and averaging down	Bullish (contrarian)	StockTwits	$23.05 buy on 10/7; 'adding down here at scale' on 10/14; @alexx013 added at 21.93
Short and put chatter	Bearish	StockTwits	'ez short under 22', 'Loading all puts above 23' (10/14)
Reported new 52-week low	Bearish	StockTwits (@Stocktwits52wLows)	Single automated-looking post; unverified
Miners reversing the Aug rally	Bearish	StockTwits (@Arcides)	'acting very bad' (10/13)
Gold down >1% to ~$4,107 on hot CPI (3.7% vs 3.6%)	Bearish (macro)	StockTwits (@Techdamentals)	Unverified single post; rate-expectation driven
Long-dated call interest	Neutral / speculative	StockTwits (@greggortrades)	'40c 1/28'' at $1.76; no stance
Reddit	No signal	Reddit	Skipped by config

Bottom line: sources point in different directions. The news is neutral to mildly constructive, the retail label count tilts slightly bullish on thin and concentrated data, and price and macro evidence is bearish. The read is Mixed with a slightly sub-neutral score, low confidence, and sentiment should be weighed with fundamentals and technicals rather than treated as a price call.

News Analyst¶

KGC (Kinross Gold Corporation, NYSE): Weekly News and Macro Report, 7–14 Oct 2026¶

1. Data limits¶

FRED macro data failed. The FRED API key isn't configured, so fed funds, the 10-year yield, CPI and VIX all returned DATA_UNAVAILABLE. I haven't filled in any numbers. The macro section relies on news headlines and prediction markets, so it is directional only.
News came back as headlines only. The tool returned no article text and no timestamps. Some KGC items returned for 14 Sep–7 Oct, such as the guidance cut and the "crashing today" pieces, may be older than they look. Treat their timing as unconfirmed.
I have no KGC price or spot gold price. I couldn't check where the stock is against the analyst targets. The gold level below is inferred from prediction-market strikes.
The gold prediction markets are thin. They trade roughly $17–31K each, so they are weak evidence.

2. Macro backdrop: a hawkish, higher-yield, higher-oil regime¶

Rates and inflation - Headlines say the 10-year Treasury yield rose after hot inflation data. I can't give the CPI or yield figures. - Mortgage rates are at their highest in nearly three years, and one headline asks "Is 8% next?" - Yields are rising globally. Yahoo's Chart of the Day puts France on the "ugly side" of the bond selloff. - A BofA fund manager survey says investors won't rotate from stocks to bonds until yields reach about 5.9%. That suggests yields are already high and still climbing.

Fed expectations (Polymarket)

Market	Probability	Volume
No Fed cuts in 2026	97%	~$8.9M
Another Fed hike in 2026 (resolves 10 Dec)	86% (+8pp on the week)	~$764K
2 hikes in 2026	64%	~$176K
3 hikes in 2026	18% (+8.2pp)	~$142K
1 hike in 2026	16% (−6pp)	~$429K

The market is pricing rate hikes, not cuts. The week's move was toward more tightening.
The exact-count markets may include hikes already made this year, so I can't infer the current policy rate from them. Only the "another hike" market is clearly forward-looking.
The hike markets trade far less than the "no cuts" market, so they are less reliable.

Growth and risk sentiment - Polymarket puts a US recession by the end of 2026 at 8% (up 1pp on the week, $2.3M volume). That is low, so this looks like a stagflation-style tightening story rather than a growth scare. - BlackRock turned more bearish on stocks. Other headlines point to "bubble-like valuations" and "debt crisis chatter". - Tech was weak on rising oil and AI-trade jitters, then rebounded. Banks rose on JPMorgan and Goldman earnings, which opened Q3 earnings season.

Geopolitics and oil - WTI/Brent is around $103, per the headline "Oil falls to $103". Oil dropped when Trump said the US will not attack Iran before the midterm elections. - Polymarket gives a 16% chance the US invades Iran before 2027 (about $74M volume, the deepest market I found). That is a tail risk that could bring a haven bid. - The market gives 87% that Mojtaba Khamenei is Iran's head of state at the end of 2026. It also gives 12% for a leadership change.

3. Gold: pressure from rates, with a haven bid underneath¶

Spot is probably a bit above $4,000/oz. The October touch markets are:

Strike	Probability
Touch $4,000 (low)	54%
Touch $3,900 (low)	28%
Touch $3,800 (low)	10%
Touch $3,700 (low)	7%
Touch $4,700 (high)	2%
Touch $4,800 (high)	1%

This is an inference and I couldn't verify spot. - The skew is to the downside. Traders see a real chance of a dip toward $3,900–4,000 and almost no chance of a spike to $4,700 or higher by month-end. - Headlines match that. Barchart says "Gold Lost Its Glitter This Year", and Investing.com says Canadian miners slid as gold and silver slumped (undated). - Rising yields, hot inflation and hike pricing hurt gold. They raise the opportunity cost of holding it. - Offsetting supports: - The global bond-market stress and "debt crisis chatter". - Oil near $103 and the Iran tail risk. - Equity-valuation worries. - The one-week move in the $4,000 touch market was +4.5pp, so some downside risk is being priced in.

4. KGC company news¶

Fundamentals and guidance - Production guidance cut. Headlines say Kinross lowered its 2026 and 2027 gold production outlook, citing weaker La Coipa and Round Mountain. The shares "tumbled", and one headline says KGC "fell 12%". The date isn't confirmed, but this is the main company-specific negative. - Cost risk. Zacks asks whether KGC faces "margin risks from higher unit costs in 2026". Rising costs would add to the pressure if gold weakens. - Higher capital returns. Kinross raised its return-of-capital target to 50% of free cash flow, which supports the buyback and dividend story. - Great Bear. The project targets first pour in 2029, so it is a long-dated growth driver.

Analyst actions (this week) - UBS cut its target to $28 from $30 and kept its Buy rating. The target and rating were not timestamped beyond that. - Desjardins cut its TSX target to C$53 (undated). - Both moves are modest trims. They fit the guidance cut and the softer gold backdrop, and the ratings are still positive.

Corporate and exploration - Kinross joined a C$47M strategic financing in Aquitaine Metals alongside Alpayana. This is minor, but it shows Kinross taking minority stakes in juniors. - Kinross began drilling at West Point Gold's Jefferson Canyon project, 7 km from Round Mountain. This is a possible near-mine source of feed for Round Mountain, which has the weak outlook.

Next catalyst - Q3 results are due 28 Oct 2026. I haven't confirmed the time of day.

5. Actionable takeaways for traders¶

The macro set-up leans against gold equities in the near term. Hot inflation, rising yields and hike pricing are the usual headwinds for gold. A further move up in yields or the dollar would likely push gold toward the $3,900–4,000 area.
The upside catalysts are event-driven. They are a break in the Iran de-escalation, a disorderly bond selloff, or an equity drawdown that triggers haven flows. The 16% Iran-invasion odds are the main tail.
KGC has company-specific risk on top of gold. The guidance cut and unit-cost concerns make it more sensitive to a gold drop than a clean producer would be. Operating leverage cuts both ways: if gold holds above $4,000, margins and the 50%-of-FCF return policy stay supportive.
The 28 Oct Q3 print is the next big event. Key items to watch:
Production against the lowered guidance.
Unit costs and all-in sustaining costs.
Realized gold price and free cash flow.
Buyback pace under the new return policy.
Updates on Round Mountain, La Coipa and Great Bear.
Other macro dates to watch: the next CPI print, Fed meetings through 10 Dec, Treasury auctions and oil headlines tied to Iran.
The sell-side is still constructive. Targets are being trimmed, not rating-downgraded. Without a price, I can't say how much upside they imply.

6. Summary table¶

Area	Key point	Evidence	Direction for KGC	Reliability
Inflation and rates	Hot inflation print; 10-year yield rising; mortgage rates near 3-year high	Yahoo/AlphaCheck headlines	Bearish for gold equities	Medium (no FRED figures)
Fed path	97% no cuts in 2026; 86% another hike by 10 Dec; 2 hikes 64%	Polymarket	Bearish for gold	Medium (hike markets thinly traded)
Growth	US recession by end-2026 at 8%	Polymarket, $2.3M volume	Neutral	Medium-high
Global bonds and valuations	Worldwide yield surge; France stressed; "bubble-like" valuations; BlackRock more bearish on stocks	Yahoo headlines	Mildly bullish haven support	Medium (headlines only)
Oil and geopolitics	Oil about $103; Trump says no Iran attack before midterms; US invasion of Iran before 2027 at 16%	Yahoo; Polymarket ($74M)	Tail-risk haven upside	Medium-high
Gold level	Probably just above $4,000; 54% chance of touching $4,000, 28% $3,900; upside tails near 1–2%	Polymarket gold strikes	Skew to the downside	Low (thin volume, inferred)
Gold narrative	"Gold lost its glitter this year"; miners slid on a gold and silver slump	Barchart, Investing.com	Bearish tone	Low-medium (undated)
Company guidance	2026–27 production outlook lowered (La Coipa, Round Mountain); shares fell sharply	MT Newswires, Proactive, Motley Fool	Bearish; main idiosyncratic risk	Medium (timing unconfirmed)
Costs	Unit-cost margin risk flagged for 2026	Zacks	Bearish if gold softens	Low-medium
Capital returns	Return target raised to 50% of FCF	Simply Wall St., Zacks, MarketBeat	Supportive	Medium
Growth pipeline	Great Bear first pour targeted for 2029; Jefferson Canyon drilling near Round Mountain; Aquitaine stake	MarketBeat, TMX Newsfile	Long-dated positive	Medium
Analysts	UBS target $28 (from $30), Buy; Desjardins C$53 (lowered)	MT Newswires	Modestly negative revisions, ratings intact	Medium
Next catalyst	Q3 results 28 Oct 2026	GlobeNewswire	High-volatility event	High
Data gaps	FRED macro unavailable; no KGC price or spot gold; headline-only news	Tool errors	Limits precision	n/a

Fundamentals Analyst¶

KGC (Kinross Gold Corporation) Fundamental Report¶

Date: 2026-10-14 | Sector: Basic Materials / Gold | Exchange: NYQ | Latest reported quarter: Q2 2026 (period ended 2026-06-30)

Scope note: The tools return the latest quarterly filings and snapshot ratios. They have no news feed or week-specific window, so nothing here covers events from the past week. Where I derived a figure from the tool output, I say so.

1. Snapshot and Valuation¶

Metric	Value
Market cap	~$26.38B
P/E (TTM) / Forward P/E	8.46x / 7.99x
PEG	1.12
Price/Book	2.73x (book value/share $8.14)
EPS (TTM) / Forward EPS	$2.63 / $2.78
Dividend yield	0.68%
Beta	1.52
52-week range	$21.90 – $39.11
50-day / 200-day average	$27.62 / $29.30

Implied share price (derived, not quoted): About $22. Two calculations agree: market cap ÷ 1.194B shares ≈ $22.09, and P/E × EPS ≈ $22.24. That puts the stock: - roughly at its 52-week low ($21.90) and about 43% below the high; - about 20% below its 50-day average and about 24% below its 200-day average.

This is a sharp recent de-rating. The fundamentals tools can't explain it. The gold price, news flow and technicals need a separate check.

Derived valuation metrics: - EV ≈ $26.38B + $0.74B debt − $2.66B cash ≈ $24.5B. - EV/EBITDA is about 4.5x, using the vendor's $5.39B TTM EBITDA. - FCF yield is about 11.4%, using the vendor's $2.99B TTM FCF. - P/FCF is about 8.8x.

All of these are low for a profitable producer. The market is either pricing in a lower gold price or doubting that current margins can last.

Forward EPS looks conservative. The $2.78 forward EPS is only about 6% above TTM EPS. The last two quarters' EPS ($0.71 and $0.70) annualize to about $2.80–2.84. So consensus appears to assume flat-to-lower earnings from here. That points to lower gold-price or higher-cost assumptions, though the tools don't confirm this.

2. Income Statement (Quarterly, USD)¶

	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26
Revenue	$1,728.5M	$1,802.1M	$2,023.0M	$2,407.7M	$2,238.1M
Cost of revenue	$831.3M	$884.0M	$784.9M	$966.2M	$950.2M
Gross profit	$897.2M	$918.1M	$1,238.1M	$1,441.5M	$1,287.9M
Gross margin	51.9%	50.9%	61.2%	59.9%	57.5%
Operating income	$762.1M	$797.5M	$1,110.7M	$1,326.3M	$1,174.5M
Operating margin	44.1%	44.3%	54.9%	55.1%	52.5%
EBITDA	$1,012.6M	$1,144.9M	$1,386.8M	$1,604.1M	$1,465.9M
Pre-tax income	$729.5M	$841.4M	$1,097.6M	$1,321.2M	$1,182.0M
Tax provision	$170.9M	$232.3M	$184.7M	$465.2M	$330.2M
Effective tax rate	23.4%	27.6%	16.8%	35.2%	27.9%
Net income (to common)	$530.7M	$584.9M	$906.5M	$843.0M	$844.2M
Diluted EPS	$0.43	$0.48	n/a (≈$0.76 derived)	$0.70	$0.71

Key takeaways 1. Year-over-year growth is strong. Q2'26 revenue rose +29.5% and EPS rose about 65% ($0.43 to $0.71). Costs grew only about 14%, so operating leverage is large. 2. Sequential momentum slowed in Q2'26. - Revenue fell 7.0% from Q1, while cost of revenue fell only 1.7%. - Gross margin dropped about 2.4 points and operating margin about 2.6 points. - Pre-tax income fell 10.5% QoQ. - The tool does not say whether the revenue decline came from lower volumes or lower realized prices. 3. Earnings quality: the flat net income was helped by tax. Net income held at about $844M only because the effective tax rate fell from 35.2% to 27.9%. Q4'25's $906M was also flattered by an unusually low 16.8% rate. Pre-tax income is the cleaner trend, and it is down for two straight quarters. 4. Overhead is small and stable. G&A was $32.4M in Q2 (down from $44.9M in Q1). Interest expense fell to about $8M a quarter from about $20M after the Q4'25 debt paydown. Net interest income is now positive ($11.4M). 5. Net margin was 37.7% in Q2. The TTM profit margin is 37.5%. 6. Profitability ratios are strong. ROE is 37.0%, ROA is 21.4%, and TTM operating margin is 52.5%.

3. Balance Sheet (as of 2026-06-30)¶

Item	Q2'25	Q4'25	Q1'26	Q2'26
Cash & equivalents	$1,136.5M	$1,742.3M	$2,185.0M	$2,656.4M
Inventory	$1,344.7M	$1,370.3M	$1,315.2M	$1,385.0M
Total current assets	$2,748.6M	$3,288.5M	$3,675.0M	$4,241.7M
Net PP&E	$7,972.7M	$8,289.4M	$8,310.0M	$8,505.2M
Total assets	$11,463.4M	$12,411.1M	$12,883.8M	$13,596.6M
Current liabilities	$966.7M	$1,399.6M	$1,293.0M	$1,466.6M
Long-term debt	$1,236.4M	$738.2M	$738.5M	$738.8M
Total liabilities	$3,775.4M	$3,717.0M	$3,662.9M	$3,822.0M
Shareholders' equity	$7,553.7M	$8,576.0M	$9,098.3M	$9,653.3M
Working capital	$1,781.9M	$1,888.9M	$2,382.0M	$2,775.1M

Key takeaways - The company has net cash. Cash of $2.66B against $0.74B of debt gives about $1.9B net cash (derived). Debt/equity is about 0.08x and the current ratio is 2.89x. Solvency risk is minimal. - Deleveraging is complete. A $502M debt repayment in Q4'25 took debt from $1.24B to $0.74B, with no further reduction since. - Equity is up about 28% YoY. Retained earnings are still negative (−$4.35B) but have improved by about $3.0B in a year. - Watch items: - Income tax payable is $587.5M, roughly double its level a year ago ($285.9M). Cash taxes may keep weighing on cash flow. - Long-term provisions (likely reclamation and closure) are about $976M. - Deferred tax liabilities are about $584M. - Minority interest is small ($121M). - Data caveat: Shares outstanding are identical in Q1 and Q2'26 (1,194,109,463), even though Q2 buybacks were $230M. The Q2 share count is probably stale. Diluted average shares did fall from 1,204M to 1,194M.

4. Cash Flow (Quarterly, USD)¶

	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26
Operating cash flow	$992.4M	$1,024.1M	$1,146.9M	$1,139.5M	$1,145.9M
Capex	−$306.1M	−$312.2M	−$368.2M	−$283.2M	−$411.0M
Free cash flow	$686.3M	$711.9M	$778.7M	$856.3M	$734.9M
Buybacks	−$170.1M	−$165.1M	−$265.1M	−$250.1M	−$230.0M
Dividends	−$36.7M	−$36.4M	−$42.1M	−$47.9M	−$47.6M
Debt repayment	−$1.5M	−$2.0M	−$502.2M	−$2.2M	−$2.0M
Ending cash	$1,136.5M	$1,721.7M	$1,742.3M	$2,185.0M	$2,656.4M

Key takeaways 1. Operating cash flow is steady at about $1.14B a quarter for three straight quarters, even though pre-tax income dipped in Q2. 2. Capex jumped in Q2. At $411M it was +45% QoQ and +34% YoY, which pulled FCF down to $735M from $856M. TTM capex is about $1.37B. This is the main swing factor in FCF. It is worth checking whether the rise is growth spending or timing. 3. Cash taxes are heavy. Cash taxes were −$326.9M in Q2 and −$448.6M in Q1, against only −$57M to −$73M in the prior two quarters. This is a real drag on cash conversion. In this data, the "Deferred Tax" line equals the tax provision exactly, which looks like a vendor mapping quirk, so I would not read it as a true deferred-tax figure. 4. TTM FCF is about $3.08B (sum of four quarters), against $2.99B in the fundamentals snapshot. The difference is probably a vendor definition issue. 5. Shareholder returns are buyback-led. - TTM buybacks are about $910M (about 3.5% of market cap). - TTM dividends are about $174M. - Total yield is about 4.1%, roughly 35% of FCF. - The dividend is only about $0.04 a share per quarter, a payout ratio under 10%. - Diluted share count is down about 2.9% YoY. 6. Cash build. Cash rose about $473M in Q2 and $443M in Q1 even after returns. There is room for more buybacks, a higher dividend or M&A.

5. Insider Transactions¶

The tool returned no insider transactions reported for KGC. This means there is no data and no signal. It does not confirm that insiders did nothing. Check other sources (SEC Form 4 or SEDI filings) before drawing any conclusion.

6. Overall Assessment for Traders¶

Bullish fundamental factors - Earnings and cash generation are strong. Operating margin is above 50% and OCF is about $1.14B a quarter. - The balance sheet is very strong, with about $1.9B net cash and 0.08x debt/equity. - Valuation is low: about 8x earnings, about 4.5x EV/EBITDA and an FCF yield of about 11%. - Buybacks are ongoing and the share count is shrinking. - The stock is near its 52-week low while the reported business is near peak profitability. That is a possible dislocation, if the cause is price-driven and not company-specific.

Bearish and risk factors - Sequential momentum softened in Q2: revenue −7%, pre-tax income −10.5% and margins down 2–3 points. - Net income was held up by a lower tax rate, not by operations. - Q2 capex jumped 45% and cash taxes are rising, with $587M of tax payable outstanding. - Forward EPS implies no growth, so analysts may expect peak earnings. - Beta is 1.52, and the stock is well below its 50-day and 200-day averages, which is a downtrend. - Earnings are likely highly sensitive to the gold price, which these tools don't show.

Gaps for other analysts to fill - Gold price trend and what drove the recent drop to about $22. - News and catalysts: the Q3 2026 earnings date (likely in the coming weeks, so confirm it), production guidance, unit costs (AISC) and project updates. - Technicals and momentum. - Insider and ownership data from another source.

7. Summary Table¶

Category	Key Point	Reading
Valuation	P/E 8.5x, forward P/E 8.0x, EV/EBITDA about 4.5x, FCF yield about 11%	Cheap
Price context	About $22 (implied), at the 52-week low, about 20% below the 50-day and 24% below the 200-day average	Strong downtrend; cause unknown
Revenue	Q2'26 $2.24B, +29.5% YoY, −7.0% QoQ	Strong YoY, softer QoQ
Margins	Gross 57.5%, operating 52.5%, net 37.7% (all down 2–3 points QoQ)	Elite but compressing
EPS	Q2 $0.71 (vs $0.43 a year ago); TTM $2.63; forward $2.78	Forward EPS looks conservative
Earnings quality	Net income flat only because the tax rate fell from 35.2% to 27.9%; pre-tax income −10.5% QoQ	Caution
Operating cash flow	About $1.14B a quarter, steady	Positive
Capex / FCF	Q2 capex $411M (+45% QoQ); FCF $735M vs $856M in Q1	Watch
Cash taxes	$327M in Q2, $449M in Q1; income tax payable $587M	FCF headwind
Balance sheet	Cash $2.66B, debt $0.74B, net cash about $1.9B, current ratio 2.89	Very strong
Debt actions	$502M repaid in Q4'25; interest expense down to about $8M a quarter	Done
Returns	TTM buybacks about $910M, dividends about $174M, yield about 4.1%	Buyback-led
Dividend	0.68% yield, payout under 10%	Small
Profitability	ROE 37.0%, ROA 21.4%	Excellent
Risk	Beta 1.52; gold-price sensitivity; reclamation provisions about $976M	Elevated
Insiders	No transactions reported	No signal; verify elsewhere
Data caveats	Q2 share count stale; Q4'25 EPS blank; vendor TTM EBITDA and FCF differ from summed quarters	Minor

II. Research Team Decision¶

Bull Researcher¶

Bull Analyst: # Bull Case for KGC (Kinross Gold, NYSE) at $22.24

The bear has not spoken yet, so I'll make my case and also take on the objections I expect.

The thesis in one line¶

KGC is a business earning peak-level profits and returning cash. It trades at 8x earnings, near its 52-week low, after a drawdown of about 41% from its January close.

1. The valuation assumes a collapse that the numbers don't show¶

Metric	KGC today
P/E (TTM / forward)	8.5x / 8.0x
EV/EBITDA (derived)	~4.5x
FCF yield (derived)	~11.4%
Net cash (derived)	~$1.9B (about 7% of market cap)
ROE / operating margin	37% / 52.5%

Q2 2026 revenue was up 29.5% year over year and EPS rose from $0.43 to $0.71. Operating cash flow has held at about $1.14B per quarter for three straight quarters. A year ago the stock traded at today's price (22.38 on 4 Nov 2025). Since then, quarterly EPS is up about 65%, equity is up about 28%, and the balance sheet has moved from roughly flat net debt to $1.9B of net cash. The share price is the same while the business is much stronger.

Stress test (my illustrative math). Suppose the guidance cut and gold weakness knock 30% off free cash flow, from about $3.0B to about $2.1B. The FCF yield is still about 8%, and the P/E is only about 12x on lower earnings. That is not a distressed multiple for a company with net cash. The market is pricing something worse than a 30% earnings hit.

2. Capital returns support the stock¶

Trailing buybacks were about $910M and dividends about $174M, a total yield of about 4.1%.
Kinross raised its return target to 50% of free cash flow. That is a policy commitment and not a retail rumor.
The cash pile grew by about $470M in Q2 even after returns, and the balance sheet is fully deleveraged after the $502M debt paydown in Q4 2025. The same $230M quarterly buyback retires more shares at $22 than it did at $35.

3. The growth pipeline is real¶

Great Bear targets first pour in 2029.
Jefferson Canyon drilling, 7 km from Round Mountain, could support the asset with the weakest outlook.
Aquitaine Metals gives minority exposure to exploration upside.

I'll concede that these are long-dated and small next to the cash flow. But they are free options on a stock priced at 8x earnings.

4. Where I expect the bear to push¶

"Every trend indicator is down." This is the bear's strongest ground and I won't deny it. All three SuperTrend tiers are down, the moving-average stack is bearish, and ADX is 36.8. But several signals suggest selling pressure is fading even as the price makes new lows: - RSI is 29.2. - MACD (-1.38) sits above its 8 Oct trough (-1.43) while price is lower. - MFI (~0.25) is above its 1 Oct and 7 Oct troughs (0.17), which means selling is not accelerating. - Price is still 1.4 ATR above the lower Bollinger band, and the Z-score of -1.3 shows it isn't at a statistical extreme.

The stock bounced from the same zone twice. It went from about 22.50 in July to 33.48 by 25 Aug (+49%), and from 22.38 in November 2025 to 28.23 by 1 Dec (+26%). Today's close is below July's low, so I won't call this a confirmed double bottom.

"Management cut production guidance." This is the main company-specific negative, and it is real. The cuts cite La Coipa and Round Mountain for 2026 and 2027. It likely lines up with the -11.6% breakdown on 24 Sept, but the headline dates are unconfirmed. Since 27.62, about $6.4B of market cap has been erased. Some of that is gold and macro, but it is still more than two years of trailing free cash flow. Unless the cut is far larger than the headlines suggest, the market looks to be overpricing it. The Q3 print on 28 Oct will show how big the cut really is. The bar has already been reset, and a clean print would be a strong catalyst.

"Gold is under pressure from the Fed." The hawkish outlook is already priced in, with Polymarket at 97% for no cuts in 2026 and 86% for another hike. Gold is still around $4,100 (single-source and unverified). Polymarket gives only a 10% chance of touching $3,800 in October, so the market is not pricing a gold collapse. The tail risks are on the other side: oil near $103, bond-market stress across Europe, "debt crisis" chatter, and a 16% chance of a US invasion of Iran. KGC's beta of 1.52 means the leverage that hurts on the way down helps on the way up.

"Earnings quality is weak." I'll give some ground. Pre-tax income fell 10.5% quarter over quarter, margins slipped 2–3 points, and Q2 capex jumped 45% to $411M. But the Q1 tax rate of 35.2% was the outlier. The Q2 rate of 27.9% is a normalization and not a flattering one. Operating cash flow was flat at $1.14B, and even with the capex jump, Q2 FCF was $735M. I'd want to know whether the capex is growth spending or timing.

"Forward EPS is flat, so this is peak earnings." The $2.78 forward EPS is only 6% above TTM. If this is peak earnings, 8x is still a low multiple for a net-cash company with a 50%-of-FCF return policy. A 10x multiple on $2.78 gives about $27.80, which is almost exactly UBS's $28 target (+26%, Buy maintained). A move back to the 200-day average of 29.20 would be +31%.

5. Where I could be wrong¶

A close below 21.90, with acceptance near the 20.85 lower band, would mean the trend is still in charge.
The first confirmation would be a reclaim of 23.44–23.63. A daily close above 25.27 would flip the daily trend.
A big miss on production or unit costs on 28 Oct would weaken my argument that the guidance cut is priced in.
Today's bar may be provisional, and I could not verify the gold price.

The bottom line¶

At 8x earnings and an 11% FCF yield, with $1.9B of net cash and a rising buyback, the market is asking investors to assume that KGC's earnings fall by a third or more. That might happen, but it hasn't shown up in the reported numbers.

My question for the bear: what gold price and what production level are you assuming that justify an 8x multiple? And if the 28 Oct print confirms the cash flow is intact, what is left of the bearish case besides the chart? Bull Analyst: # Bull Rebuttal: KGC at $22.24

You landed some real hits, so I'll start there.

What I concede - No reversal signal. RSI shows no bullish divergence, the MACD divergence is marginal, and a Z-score of -1.3 means the stock isn't stretched. The double-bottom is gone, and I'm not calling a bottom. - "Priced in" on the Fed was too strong. Hike odds rose 8pp this week. - Consensus EPS is roughly flat. Your sensitivity arithmetic checks out, and the multiple has to carry the thesis. - The tax cushion is gone. Pre-tax income fell 10.5% quarter over quarter. - The retail posts come from one account, and I never relied on them.

Here is where I think the case breaks.

1. You can't call 8x a mean-reversion multiple and then apply it to mean-reverted earnings¶

You open by saying 8x on peak earnings is the market capitalizing mean reversion. Your stress test then takes 8.5x × $1.84 = $15.60. That counts the pessimism twice. If 8.5x already discounts a decline, the multiple on the declined earnings should be higher, not unchanged.

The multiple also isn't a constant. On 23 Sept KGC closed at 27.62, which is 10.5x trailing and 9.9x forward on the same reported financials. In three weeks the reported numbers haven't changed. What changed is guidance of unknown size, a gold wobble and a hot CPI print. So the real question is how much earnings power was lost, not whether 8x is "the market's answer."

The "peak" framing also overstates the earnings decline. The peak quarter was Q1, and pre-tax income is down 10.5% from it. The stock is down 41% from its 28 Jan close, while forward EPS ($2.78) is still above TTM ($2.63).

2. Your table is an EPS table. Here it is in cash¶

Miners are valued on cash flow, and capex sits between EPS and FCF. I start from Q2 annualized FCF, which includes the capex spike: $735M × 4 = $2.94B, against $2.99B TTM. I then apply your flat-cost, 28%-tax assumption (my illustrative math).

Revenue vs Q2 run-rate	FCF	FCF yield on $26.4B	50%-of-FCF return
0%	$2.94B	11.1%	$1.47B
-5%	$2.62B	9.9%	$1.31B
-10%	$2.30B	8.7%	$1.15B
-15%	$1.97B	7.5%	$0.99B

Flat costs are the harshest way to lose revenue. If the decline is volume-driven, variable costs fall. If it's price-driven, royalties likely fall (inference, since there is no royalty data).
Your worst row still leaves a 7.5% FCF yield and net cash.
The capital-return policy isn't procyclical in the way you describe. By your own numbers, $1.05B in your downside case is about the same as the $1.08B returned over the trailing year. Returns stay flat in dollars through a 30% FCF cut. In the base case the policy lifts returns about 36–39% to roughly $1.47–1.5B, a ~5.6% yield. The $2.66B of cash means the company doesn't have to cut.

3. The "turn" in Q2 is thinner than it looks¶

Costs didn't rise. Cost of revenue fell $16M (-1.7%) while revenue fell $170M. The ratio rose because revenue fell, not because costs grew. Year over year, costs are +14% against revenue +29.5%.
"Unit costs are rising" has weak support. It rests on a Zacks headline phrased as a question, which the news report rates low-to-medium reliability. AISC isn't in our data.
Q4'25 is a flattering baseline. Its 38.8% cost ratio was the outlier. The ratio was 48.1% in Q2'25 and 49.1% in Q3'25. Q2'26's 42.5% is still 5.6 points better than a year ago.
Capex is lumpy, not clearly ramping. Q2's $411M is +45% only because Q1's $283M was the low. H1 capex was $694M against a TTM-pace half of $687M.
"TTM FCF is struck before the spend" doesn't hold. Q2 is in the TTM, and Q2 annualized is $2.94B. Great Bear's cost isn't in the data, as you noted.
Net cash survives your adjustments. Take $2.66B of cash less $0.74B of debt, then also subtract the $587M of tax payable and the ~$976M of provisions. That leaves about $0.35B, still net cash. Cash alone covers current liabilities (which already include the tax payable) 1.8x.

4. The 28 Oct print isn't as binary as you make it¶

The guidance cut came with near-complete Q3 visibility. The timing is unconfirmed, but if the 24 Sept date is right, the cut came six days before quarter-end. Management had nearly all of Q3 production in hand. The unknowns on 28 Oct are unit costs, capex and buyback pace, not a surprise volume number.
Most of the "9% post-guidance drop" is today. From 24.42 to 23.44, the stock lost only 4% over the following two and a half weeks. The other 5.1 points came today, which you attribute to a macro headline.
The sell-side trims are small next to the price move. UBS cut its target about 7% and kept its Buy. Since 23 Sept the stock is down about 19%. If this is the early phase of estimate cuts, the cuts so far are a fraction of what the price already did.
Today's move looks outsized for the gold move. Gold fell about 1% (single-source, unverified). A permanent 1% lower gold price is roughly $64M of annual after-tax earnings, or about $0.5B of value at 8.5x. KGC lost about $1.4B of market cap, roughly 2.6x that. Beta explains some of it, but not all.

Your "what would change my mind" list is production within lowered guidance, flat or lower unit costs, and capex explained as timing. A company that reset guidance days before quarter-end is well placed to deliver exactly that.

5. How I'd use the technicals¶

The trend tools say wait for confirmation, so I'll use them for risk and not for conviction: - Invalidation: a close below 21.90, with the 20.85 band as the next reference. - Sizing: one ATR is $0.96, or 4.3%. Size so a move to 20.85 (about -6%) is tolerable, because gaps like -11.6% and -5.1% can jump stops. - Confirmation: 23.63, then a close above 25.27 for the daily flip.

Valuation says what the stock is worth, and the tape says when. I'd rather be early and small than claim certainty.

Bottom line¶

We now agree on the framework. The disagreement is how much revenue falls from the Q2 run-rate, and for how long. Your table needs a sustained ~10% shortfall at 10x for $22 to be fair. Even then FCF yield is 8.7%, returns are roughly flat, and the company has net cash.

My questions back: 1. What gold price or production path gets you to -10% to -15%, and why would costs stay flat if volumes fall? 2. If 28 Oct delivers what your own list asks for, which row of your table are you in?

Caveats: Spot gold is unverified, today's bar may be provisional, and the guidance date is unconfirmed. The fiscal period of the $2.78 forward EPS isn't specified. My tables are illustrative: flat costs, 28% tax, and no royalties or minorities. Bull Analyst: # Bull Rebuttal: KGC at $22.24

The debate has narrowed to one question: what happens to revenue from here, and what multiple it deserves. I'll start with what you earned.

What I concede - "Strong catalyst" was loose wording. The 28 Oct print resolves uncertainty and is unlikely to surprise on volume (see §5). - Buybacks are falling, not rising ($265M, $250M, $230M). The 50%-of-FCF policy isn't in the reported numbers yet. - "Flat costs are the harshest case" is retracted. Q2 doesn't support it (see §3). - Forward EPS above TTM is a base effect, not growth. - 21.90 is not a meaningful stop. It sits 0.35 ATR away. - My 1%-gold yardstick measured level, not path. You're right that the path matters. - The tape is against me. "Early and small" means exactly that.

1. The thesis didn't shrink. I changed the reference multiple.¶

Here is what $22.24 implies against $2.78 forward EPS:

Through-cycle multiple	Implied EPS	Decline vs $2.78
8x	$2.78	0%
9x	$2.47	-11%
10x	$2.22	-20%
12x	$1.85	-33%

My opening "a third" implicitly used 12x. My rebuttal used 10x, and with the ~90% flow-through you insist on, a 10% revenue miss is a ~19% EPS miss. So the two statements are the same claim at different multiples, and I should have said so. The honest version is that the price embeds an 11–20% EPS decline at 9–10x. That is a real decline, and it is roughly "one more Q2-sized step down."

On what stops the multiple falling, I have three mechanisms and no guarantees: - Buyback accretion. At this price the policy retires roughly 5% of the shares a year. - The 28 Oct print. - Gold stabilizing.

On macro, the deep Fed market ("no cuts," $8.9M volume) is at 97%. The +8pp moves are in markets trading $142–764K. The direction is hawkish, but the incremental information is thinner than it looks.

2. Your payoff table stops at the top¶

Your table runs 0% to -15%. Q1 revenue was +7.6% above Q2, so upside rows aren't exotic. Extending your own linear EPS sensitivity ($0.27 per 5%) and showing returns vs $22.24:

Revenue vs Q2	EPS	8x	9x	10x
+10%	$3.32	+19%	+34%	+49%
+5%	$3.05	+10%	+23%	+37%
0%	$2.78	0%	+13%	+25%
-5%	$2.51	-10%	+2%	+13%
-10%	$2.24	-19%	-9%	+1%
-15%	$1.97	-29%	-20%	-11%

9x is my illustrative midpoint between 8.0x forward today and 9.9x on 23 Sept. Break-even revenue vs the Q2 run-rate is about 0% at 8x, -6% at 9x and -10% at 10x.

I'm not claiming the upside rows are likely. With volumes guided down, they need gold to do the work. But a table that goes -15% on the downside and stops at 0% on the upside isn't neutral. The 8x column also assumes the market keeps charging today's uncertainty discount after the cut has happened, which is the double-count I raised last round.

3. Operating leverage is real, two-sided and noisy¶

Quarter-to-quarter gross-profit flow-through in the data:

Step	Flow-through
Q2'25 → Q3'25	28%
Q3'25 → Q4'25	145%
Q4'25 → Q1'26	53%
Q1'26 → Q2'26	91%
Q2'25 → Q2'26 (full year)	77%

I accept ~80–90% as the working number, which is why I retract "harsh." But one quarter is a poor estimator. In Q4'25 cost of revenue fell $99M while revenue rose $221M, which looks like timing or inventory effects (inference). The leverage also works upward. If 10% of revenue is ±19% of EPS, a gold stabilization is worth more than a downside-only table credits. That is also why beta is 1.52.

"Fewer ounces over a fixed cost base raises unit costs" is plausible, but it is inference. AISC isn't in our data.

4. You get paid to wait in every row¶

Using the 50%-of-FCF policy on the FCF figures from my last table (my math, flat costs, 28% tax):

Revenue vs Q2	FCF yield	Cash returned (% of mkt cap)
0%	11.1%	5.6%
-5%	9.9%	5.0%
-10%	8.7%	4.4%
-15%	7.5%	3.7%

Buybacks. At 50% of Q2-annualized FCF ($1.47B) less ~$190M of dividends, buybacks are ~$1.28B a year, about 4.8% of market cap.
Retained cash. The other half builds net cash or funds Great Bear.
Your 5.6% vs rising yields point. The relevant comparison is the full FCF yield, since retained cash isn't lost. I can't quote the 10-year because FRED failed, and neither can you.
Policy timing. The announcement date is unconfirmed. "Not visible yet" is consistent with "not yet in effect," and Q3 is the first real test.

5. The 28 Oct print can be both low-surprise and high-value¶

Management has near-complete Q3 volume visibility, so volume is unlikely to surprise. But unit costs, capex and buyback pace are what the market is discounting, and they are the same items on your own "change my mind" list. That makes it a clean test for both of us. Thresholds (my math from the flat-cost table):

Metric	Thesis holds	Thesis breaks
Q3 gross margin	≥ ~55% (Q2: 57.5%)	< ~53% (the -10% row)
Q3 FCF	Near the $735M Q2 level	< ~$575M ($2.3B annualized)
Buybacks	Stepping up toward your $350M+	Still drifting down

You're right that it won't resolve 2027 volumes or gold.

6. The remaining points¶

"Estimates haven't been cut." Our tools have no revision history, and we don't know when the $2.78 was struck. What we do have is two broker target cuts (UBS and Desjardins). Neither of us can assert this either way.
Net cash. The stressed $0.35B is the harshest reading. Its role isn't to backstop a 25% equity move. It removes financing and dilution risk and lets the buyback run at lows.
Risk plan. I'll replace the price stop with a thesis stop:
Take one-third now, sized so a gap to 20.85 (-6%) is tolerable.
Add one-third after 28 Oct if the "holds" column is met.
Add the last third on a daily close above 25.27.
Cut if the "breaks" column is hit.

Valuation and timing are separate questions, and I never said the tape confirms me.

Bottom line¶

After three rounds we agree on the balance sheet, the lumpy capex, the Q2 tax normalization and the chart. The disagreement is one number. A -6% revenue move breaks even at 9x and -10% breaks even at 10x, and you are paid roughly 4–6% in cash returns while waiting. Price embeds about one more Q2-sized step down. If revenue holds, the stock is cheap. If it falls further, it is roughly fair, with the carry to show for it. I think that is a reasonable skew for a sized, staged position, though it is not a screaming margin of safety.

Questions back: 1. Below what Q3 gross margin do you consider yourself right, and above what do you concede? 2. If revenue is flat, what multiple or FCF yield is fair for a net-cash, 37%-ROE producer returning 5%+? If it's 8x, what is that anchored to?

What would change my mind: Q3 gross margin under ~53%, Q3 FCF under ~$575M, buybacks still drifting down despite the policy, or gold sustained below ~$3,900.

Caveats: - Spot gold, the guidance date and today's bar are unverified. - The forward-EPS period is unspecified. - Q2 realized gold price, AISC and royalties aren't in the data. - All tables are my illustrative math: flat costs, 28% tax, and your linear EPS slope extended upward. - The 9x multiple is my illustrative midpoint, not a forecast. Bull Analyst: # Bull Rebuttal: KGC at $22.24

After four rounds, we agree on most of the facts and arithmetic. The remaining disagreement is narrow, so I'll keep this short.

What I concede - Your base-case arithmetic checks out. Another 7% revenue step at 90-100% flow-through gives EPS of $2.40-2.44. That is about $22 at 9x and $24 at 10x. - My "thesis holds" line was only the 9x break-even. It means "don't cut," not "this pays." I revise it in §4. - The "~5% of shares retired" figure was the top row. At -10% revenue it is 3.6%, which is today's pace. The policy is not a floor, and carry doesn't cushion a drawdown. - Sizing to a gap to 20.85 was too tight. A repeat of -11.6% from here is $19.66.

1. "Another Q2-sized step" is one observation, not a base case¶

One down quarter against three up. Revenue rose in three of the last four quarterly steps, and Q2 is the only decline. I'm not claiming the trend is up. I'm saying one down quarter isn't a base case.
The flow-through is noisy. It ranges from 28% to 145% across the quarters in the data. The 90% is one observation.
The guidance cut's size isn't in the data. The tools name La Coipa and Round Mountain and give no ounces. You say the cut "points the same way" as the step, and the direction is fair. The size is unknown.
Your own list is close to the base case. You called a clean Q3 plausible, since the August rally suggests decent realized prices. You'd judge the print by the 2027 guide, which is the thing that was just cut. In my judgment, an unchanged 2027 volume guide and a backward-looking Q3 are more likely than not. If so, "revisit after 28 Oct" means paying more for the same facts. Waiting for the 25.27 close costs 13.6%.
On your base-case EPS ($2.42), the stock trades at 9.2x, not 8x. To lose money, you have to be right on earnings and the multiple also has to fall below 9.2x for a net-cash, 37%-ROE producer.

2. Waiting is not free insurance¶

The print is two weeks away. 14 October to 28 October is about ten sessions, not "four trading weeks."
Waiting avoids the downside only by also forgoing the upside. Your argument was that if the print is informative, a pre-print buy is a coin flip, and if it isn't, waiting is free. But if the print is zero-mean, "the downside it avoids" is offset in expectation by the upside it forgoes. Waiting only has positive value if you think P(bad print) is above 50%. You've said a clean Q3 is plausible.
Waiting reduces variance, and sizing does that too. Sizing keeps the upside and the carry. Your logic would also rule out every entry within two weeks of earnings.
Carry vs. ATR is a category error. A year of yield compared with one day's range isn't a risk measure. Carry is what you collect if the cash flows are real. It isn't there to offset volatility, and I won't claim it is.

3. The gold "downside skew" is mostly distance¶

The data and the bear both read the Polymarket strikes (54% to touch $4,000, 28% to touch $3,900, 1-2% for $4,700+) as a downward skew. Compare that with a driftless random walk (my calc, assuming ~22% annualized vol and the unverified ~$4,107 spot):

Strike	Distance from spot	Polymarket (touch, Oct)	Random walk
$4,000	-2.6%	54%	~58%
$3,900	-5.0%	28%	~28%
$3,800	-7.5%	10%	~10%
$4,700	+14.4%	2%	<1%

The $4,000 strike is simply much closer to spot than the $4,700 strike. The pricing matches symmetric volatility, and the upside tail is if anything fatter than a random walk implies. This isn't evidence of directional drift, and these are thin markets.

Touch odds also overstate sustained levels. For the -10% row you need roughly gold -5% and volume -5% for a year, not one touch. Your own decomposition puts that at about $3,900 sustained (the touch odds are only a loose proxy). I'm not saying that's impossible, but it takes more than a hawkish week.

4. A cleaner test for 28 Oct¶

I'm moving toward your thresholds. Mine were a "don't cut" line, and a pass should clear the 9x break-even.

Q3 result	Reading	Action
Gross margin ≥ ~57%, FCF ≥ ~$735M, 2027 guide unchanged	Clean	Add the next tranche
Gross margin ~53-57%	No edge (your "in between")	Hold, don't add
Gross margin < ~53%, FCF < ~$575M, or unit costs up despite volume	Break	Cut

I'd treat the buyback pace separately. A $300M+ quarter would be a good policy signal, but it isn't an earnings test. You said "not yet in effect" fits the data, so making it a precondition for being wrong sets the bar too high.

5. The position, resized¶

Stops don't protect against the gap. Neither of us thinks a stop works through a gap like -11.6%. Sizing is the only protection, for my plan and for yours.
Size the starter for a gap to $19.66. It should be a rounding error, not a decision. If that makes the starter too small to matter, then wait. For someone who can't hold a tranche through a -12% gap, your "avoid until 28 Oct" is a legitimate answer.
The staging is unchanged. Add on a clean print, add again on a daily close above 25.27, and cut on the "break" column.

Bottom line¶

Your base case is fair value at 9x. Flat revenue is cheap, and losing money takes a sustained revenue drop of roughly 10% or more (at 10x), with a multiple below 9x and no stabilization in gold. You get 3.6-5.6% in cash returns while you wait, plus a net-cash balance sheet. It isn't a screaming bargain, as I said last round. It is a reasonable bet for a small starter that gets larger only if the evidence arrives.

The two of us now differ over one-third of a position for ten sessions. What I'd ask you: if the print is clean, the 2027 guide holds, and the stock is up 8% by 29 Oct, what multiple do you pay then, and what does your entry rule say?

What would change my mind: Q3 gross margin below ~53%, FCF below ~$575M, a lower 2027 volume guide, buybacks still falling despite the policy, or gold sustained below ~$3,900.

Caveats: - Spot gold (~$4,107), the guidance date and today's bar are unverified. - Realized gold prices, AISC, royalties and the size of the guidance cut aren't in the data. - The ~22% gold vol is my assumption. - The 90% flow-through is one quarter. - All tables are my illustrative math, not forecasts. Bull Analyst: # Bull Closing Argument: KGC at $22.24

Your closing is the cleanest statement of the disagreement so far. We now share the facts, the arithmetic and the Q3 decision table. What's left is whether a rounding-error starter makes sense for ten sessions. I'll take your concessions first.

What I concede - Carry doesn't matter over ten sessions. It is about 0.1-0.2% against a 4.3% ATR. It matters over a year, not a fortnight. - On your base case, $22.24 is fair, not cheap. $2.42 EPS puts the stock at 9.2x. I'm not claiming a bargain unless revenue holds. - A clean Q3 doesn't resolve gold or 2027 revenue. - The oversold readings are not a buy signal. The RSI shows no bullish divergence, the Z-score is -1.3, and MACD has no cross. I'm not calling a bottom. - Estimate revisions are unverifiable. I can't check them, and neither can you.

1. Your waiting rule costs up to 12%, not 8%¶

Your example of a +8% pop to $24.02 is 8.6x forward. But your stated ceiling is ~$25, which is +12.4% from here. That is what the rule costs in the world where the thesis is right.

Your §3 also says the print resolves costs and volume but not gold or 2027, and gold is the variable that sets the revenue row. So the 8-12% buys the cost half of the question, not the revenue half. That can still be worth paying for, but it is a premium for partial information.

2. Apply your gold-skew standard to the tape¶

You withdrew "the skew points down" because the strikes were mostly distance. The same discipline applies to the chart. - ADX 36.8 is largely one gap day. The technical report says the 24 Sept gap-down drove the jump from 4-5 to 39.56. - The "lower highs, lower lows" description was equally true on 20 July. Highs ran 37.92, 36.84, 34.84 and lows ran 26.47, 23.63, 22.50. The stock was down about 41% from its January close then too, and the next five weeks returned +49%. - You're right that the rally was erased. That cuts against reading the tape either way. The stock has round-tripped $22-33 for three months, and trend tools lag at both ends. - Today's close is only 1.2% below the July low. That is a marginal break, and it could be a breakdown or a failed one.

I'm not claiming a bounce is due. But "the only information flowing in the window points the wrong way" is a drift view, and you told me you don't hold one. If neither of us has a drift view, the tape gives no edge over ten sessions in either direction.

3. On your own base case, the shape is slightly favorable¶

Scenario (9x / 10x on EPS)	Return vs $22.24
Your base case ($2.42, 9x / 10x)	-2% / +9%
Revenue flat ($2.78, 9x / 10x)	+13% / +25%
Revenue -10% ($2.24, 9x / 10x)	-9% / +1%

Add roughly 3.6-4.1% a year of cash returned (my estimate from the -10% row and the TTM pace).
A double-digit loss needs a deeper-than-base-case revenue step and a multiple below 9x. At $2.42 and 8x, the stock is $19.36, about -13%.
You have withdrawn the flat-cost, capex-ramp, thin-cushion and gold-skew arguments. What remains is the multiple trend, one quarter of 90% flow-through, and a gold call with no demonstrated drift.

The multiple did fall from 9.9x forward on 23 Sept to 8.0x. You're right that nothing enforces 9.2x, but nothing enforces 8x either.

4. Where our plans converge¶

You said a price near $20 with no fundamental change would make you take it more seriously. That is 8.3x on your own base case and about 10% below today. So we aren't disagreeing about the thesis. We disagree about a ~10% price band and one tranche.

My plan: - Starter: a third of the intended position, sized so a gap to $19.66 (-11.6%) is a rounding error. - Add: on your clean-print row (gross margin ≥57%, FCF ≥$735M, flat or lower unit costs, 2027 guide unchanged), and again on a daily close above 25.27. - Cut: on the "break" row (gross margin <53%, FCF <$575M, unit costs up, or a lower 2027 guide). - Calendar: you haven't checked for an FOMC decision near 28 Oct, and the tools don't say. My unverified recollection is that the October meeting is 27-28 Oct. If so, it argues for keeping the starter small, and it affects your post-print entry as well as mine.

If the starter is too small to matter, then your "wait until 28 Oct" and my plan differ by very little. If you can't hold a tranche through a -12% gap, waiting is legitimate.

Bottom line¶

KGC trades at 8.0x forward earnings, an ~11% FCF yield and net cash. The cost, capex and balance-sheet objections have been narrowed or withdrawn. On your base case the stock is fairly priced with modest carry. If revenue holds, it is cheap by 13-25%. I think that justifies a small, staged position that grows only if the evidence arrives. It is not a screaming margin of safety, and I haven't claimed it is.

What would change my mind: - Q3 gross margin below ~53% - Q3 FCF below ~$575M - A lower 2027 volume guide - Buybacks still falling after the print - Gold sustained below ~$3,900

Caveats: - Spot gold (~$4,107), the guidance date and today's bar are unverified. - Realized gold, AISC, royalties and the size of the guidance cut aren't in the data. - The 90% flow-through comes from one quarter, with a historical range of 28-145%. - The FOMC date comes from my memory, not the tools. - All tables are illustrative math, not forecasts.

Bear Researcher¶

Bear Analyst: # Bear Case for KGC at $22.24

Your balance sheet is clean, your cash flow is real, and I'm not arguing solvency risk. My argument is about the equity: it is priced as a peak-earnings gold producer, and almost everything in the data points the wrong way from here.

Your thesis line concedes the core point: "a business earning peak-level profits." At peak earnings, a cyclical producer trades at 8x because the market is capitalizing mean reversion. A multiple that low on peak earnings is not a discount.

1. Consensus assumes nothing changes¶

The $2.78 forward EPS is roughly Q2 annualized ($0.71 × 4 ≈ $2.80–2.84). So consensus assumes zero deterioration from Q2, even though: - management cut 2026–27 production guidance, - gold is under pressure from the rates regime, and - unit costs are rising.

Either the estimate already includes the guidance cut, in which case it needs gold to hold at its peak, or it doesn't, in which case cuts are still coming. The data doesn't say which. Neither is comfortable.

My sensitivity uses the Q2 revenue run-rate (about $8.95B), ~28% tax and 1.194B shares. It holds costs flat, which is generous given the cost trend below, and ignores royalties and minorities.

Revenue vs Q2 run-rate	EPS (approx.)	At 8x	At 10x
0%	$2.78	$22.2	$27.8
-5%	$2.51	$20.1	$25.1
-10%	$2.24	$17.9	$22.4
-15%	$1.97	$15.8	$19.7

UBS's $28 target (10x forward EPS) requires no revenue decline at all. At your own 10x, a 10% revenue shortfall puts the stock exactly where it trades today. I'm also skeptical of the 10x. The 8x on the screen is the market's current answer to what a peak-margin gold miner is worth.

2. Your stress test supports my case¶

You assumed a 30% FCF hit and called the 12x P/E on lower earnings "not distressed." Hold today's 8.5x multiple on that lower EPS (~$1.84) and you get about $15.60, roughly 30% below the current price. For $22 to hold in your downside case, the multiple has to expand 40% while earnings fall. Multiples on falling cyclical earnings usually expand after estimate cuts stop, and they haven't started.

The same stress case undercuts your capital-return support. The 50%-of-FCF policy on $2.1B of FCF is about $1.05B. The company already returned ~$1.08B over the trailing year ($910M of buybacks plus $174M of dividends). So in your downside case the "raised target" adds nothing. A percent-of-FCF policy is procyclical: it shrinks when you most need it.

3. The Q2 numbers show the turn¶

Every figure in your table is from the quarter ended 30 June, 106 days ago, before the guidance cut and the gold move. Even that quarter shows the turn:

	Q4'25	Q1'26	Q2'26
Cost of revenue / revenue	38.8%	40.1%	42.5%
Gross margin	61.2%	59.9%	57.5%

Gross margin has compressed two quarters in a row.
Revenue fell 7.0% QoQ, operating income fell 11.4%, and pre-tax income fell 10.5%, the first sequential decline in the five-quarter table.
Capex rose 45% QoQ and FCF fell 14%. Great Bear's first pour is in 2029, so capex is ramping, not falling. TTM FCF of ~$3.0B is struck before most of that spend. The data doesn't give Great Bear's capital cost, so this is inference.

I'll give you the tax point: the Q2 rate of 27.9% is near the five-quarter average (~26%, my calculation). Flat EPS was helped by the rate swing from 35.2%, but there is no more tax cushion left. If pre-tax income falls again in Q3, it goes straight to EPS.

The net cash is a smaller cushion than it looks. The ~$1.9B figure is before $587M of income tax payable (about double last year's) and ~$976M of long-term provisions, probably closure and reclamation. This is a cushion, not a fortress.

4. Gold and macro are moving against you¶

You say the hawkish outlook is "already priced in." The data shows it still moving this week: - The "another hike" market rose 8pp to 86%, and the 3-hike market rose 8.2pp. - Hot CPI (3.7% vs 3.6%) pushed yields and mortgage rates higher. - Gold fell more than 1% to ~$4,107, single-source and unverified, as you noted.

Polymarket pricing of Fed policy tells you nothing about whether gold has finished adjusting to it.

Your "tail risks on the other side" are thin: - The haven bid is supposedly there already: global bond stress, "debt crisis" chatter, oil at $103. Gold fell anyway. - The Iran-invasion market (16%) runs to 2027, and Trump said no attack before the midterms. - Oil at $103 raises diesel and power costs. That is inference, but Zacks is already flagging 2026 unit-cost margin risk.

Your "10% chance of $3,800" argument uses an October-only touch market with $17–31K of volume. The skew in that same data is down (54% touch $4,000, 28% touch $3,900, 1–2% for $4,700+). Even if October is fine, it says nothing about the multi-year gold path your 8x is capitalizing.

5. Technicals¶

You call the divergences "fading selling pressure," but the technical report is blunter: - RSI: 29.2 is lower than 31.13 on 7 Oct while price made a lower close. The report explicitly says there is no bullish divergence. - MACD: the divergence is "marginal, unconfirmed," there's no bullish cross, and the line is drifting lower again. - MFI: the scale is unverified. - Z-score (-1.3) and the Bollinger position (1.4 ATR above the lower band): these mean the stock is not stretched, so there is room to fall. The report says the 20-period mean has dropped with price, which argues against assuming a snap-back. The lower band has fallen every session since 22 Sept (26.47 to 20.85). - The July low failed. You concede the close is below 22.50, so the double-bottom is gone. - Rallies get sold. The 49% August rally was erased in five weeks (33.48 to 22.24, -34%). Eight months of lower highs (36.84, 34.84, 33.48, 31.59) and lower lows. - Trend and levels: all three SuperTrend tiers are down, ADX is 36.8, and the 50 SMA is below the 200 SMA. The daily flip needs +13.6% to 25.27. Below 21.90 the only structural reference is the 20.85 band.

6. The 28 Oct "clean print" is not a free option¶

You say the bar is reset, but the stock fell about 9% after the 24 Sept breakdown (24.42 to 22.24). If the guidance cut was priced in, the selling should have stopped. It didn't, and today's drop came on a macro headline.

Q3 is the first print where lower volumes, higher unit costs and a bigger capex line can show up. The guidance cut was a mid-quarter disclosure, and its size is unknown. That is a binary event on a stock that gapped -11.6% and -5.1% in the last three weeks.

On sentiment, the retail "adding down at scale" posts come largely from one account (6 of 7 bullish posts). Dip-buying on the way down is not capitulation. Sell-side targets are being trimmed while Buys are kept, which is what the early phase of an estimate-cut cycle looks like.

Answering your questions¶

What gold price and production level justify 8x? I don't need a gold collapse. I need today's earnings not to be the floor. With volumes guided down, flat gold still means lower revenue. That is the 0% row of the table, and it is the only row where $22 looks cheap.

If 28 Oct confirms cash flow is intact, what's left besides the chart? The forward numbers, the cost trend, the rising capex, and a gold market that is moving against you. But yes, a clean print would hurt this case.

What would change my mind¶

Q3 production within the lowered guidance, flat or lower unit costs, and capex explained as timing.
A daily close above 25.27, followed by a weekly stabilization.
Gold holding above its recent range through the CPI and Fed calendar.
Consensus EPS being cut and the stock holding anyway. That would show the bad news is priced in.

Until then, you are buying a cyclical at peak margins, with estimates that haven't been cut, into a downtrend.

Caveats: spot gold, guidance timing and today's bar are all unverified, and the sentiment sample is small. The sensitivity table is my own illustrative math, not a forecast. Bear Analyst: # Bear Rebuttal: KGC at $22.24

You made some fair hits, so I'll bank those first.

What I concede - Capex. H1'26 capex was $694M against a TTM-pace half of $687M. It is lumpy, not clearly ramping, and I'm dropping it as a pillar. Great Bear's cost is still not in the data. - "Unit costs are rising." AISC isn't in our data and the Zacks item is a question. Section 2 makes the cost case better than the headline did. - $15.60 was a scenario, not a fair value. - Net cash is positive after your haircuts. I never argued solvency. - The arithmetic on "most of the 9% is today" is right.

1. Your thesis shrank between your opening and your close¶

You opened with a market "asking investors to assume that KGC's earnings fall by a third or more." You closed with: "Your table needs a sustained ~10% shortfall at 10x for $22 to be fair."

Those are very different claims. The first is a collapse, and the second is an ordinary cyclical wobble. The cheapness now depends on a re-rating from 8x to 10x, not on the earnings the market is pricing in. Your own numbers show the multiple fell from 10.5x on 23 Sept to 8.5x today with no change in reported EPS. You offer no mechanism for it to stop falling, let alone reverse, while "another hike" odds rise 8pp in a week.

Here is the payoff on your multiples:

Revenue vs Q2	EPS	8x	10x	vs $22.24 (8x / 10x)
0%	$2.78	$22.2	$27.8	0% / +25%
-5%	$2.51	$20.1	$25.1	-10% / +13%
-10%	$2.24	$17.9	$22.4	-19% / +1%
-15%	$1.97	$15.8	$19.7	-29% / -11%

At 8x you win nowhere. At 10x you win only if revenue holds within about 5% and the multiple recovers. The best case is +25% and the worst is -29%, so the payoffs are roughly symmetric. A symmetric bet with the tape and macro against it is not a margin of safety.

2. Q2 already ran your flex experiment, and costs didn't flex¶

You argue flat costs are "the harshest way to lose revenue." The one observation we have says otherwise:

Revenue fell $169.6M QoQ.
Cost of revenue fell $16.0M.
Gross profit fell $153.6M and operating income fell $151.8M.

About 90 cents of every lost revenue dollar reached operating income. Flat costs are close to the observed behavior.

This holds either way. If Q2's drop was volume-driven, costs should have fallen and didn't. If it was price-driven, costs wouldn't fall, and the next gold leg repeats the hit. The guidance cuts are at two specific mines, La Coipa and Round Mountain. Fewer ounces over a largely fixed site cost base raises unit costs. That is inference, since AISC isn't in the data, but it is the standard mechanism.

A 10% revenue shortfall is also a ~19% EPS decline ($2.78 to $2.24). That is the operating leverage you celebrated on the way up.

3. "Forward EPS above TTM" is a base effect, not growth¶

TTM EPS of $2.63 includes Q3'25 at $0.48. Swap in a $0.70 quarter and TTM is about $2.85 with no growth at all. The $2.78 forward figure implies about $0.69–0.70 a quarter, slightly below Q2's $0.71. So consensus bakes in no real deterioration, and the estimate cuts haven't started.

The stock down 41% while earnings still print near peak is also what cyclicals do. Price leads reported earnings at turning points. Q1 was the peak earnings quarter and the stock peaked in late January.

4. The 28 Oct print can't be both "not binary" and "a strong catalyst"¶

Your opening called a clean print "a strong catalyst." Your rebuttal says management has near-complete Q3 visibility, so there is no surprise volume number. If so, the print carries little new information and can't be a strong catalyst.

Three further problems: - The "six days before quarter-end" premise rests on a guidance date you call unconfirmed. The news report says those items may be older than they look. - The cut covers 2027 as well. A clean Q3 doesn't resolve 2027 volumes, and it doesn't resolve gold, the variable that drives the revenue line. - The unknowns you list for 28 Oct are unit costs, capex and buyback pace. Those are three of the four places I've been pointing, and my read on each skews negative.

5. Your own numbers shrank the cushions¶

Net cash. After subtracting the $587M tax payable and ~$976M of provisions, as you did, the cushion is ~$0.35B, about 1.3% of market cap. You opened at "about 7%." That is not backstop-sized for a 20–30% equity move.
Capital returns. In your downside case 50% of FCF is $1.05B, against $1.08B returned over the trailing year. That is no incremental support, and the raise only shows up where the stock is least in trouble.
The policy isn't visible yet. Buybacks went $265M, $250M, $230M over the last three quarters. Q2 total returns of $278M were 38% of FCF. Reaching 50% means ~$367M a quarter, a 32% step-up that hasn't happened. It is a target, not a floor.
The hurdle is rising. A ~5.6% return yield on cyclical peak cash flow competes with yields that every headline says are climbing. I can't quote the 10-year because the FRED data failed.

6. "Outsized for a 1% gold move" is the wrong yardstick¶

Your 2.6x calculation treats a single-source, unverified 1% gold move as a permanent level change. What moved today was the path: hike odds rose and the "no cuts" market sits at 97%. An equity prices the path across its reserve life, and miners are a levered claim on gold. Today's bar also broke the 22.50 and 21.92 lows on 10.4M shares (possibly provisional). That is a technical breakdown, not necessarily a mispricing.

7. Your risk plan concedes the timing point¶

Your invalidation is a close below 21.90, which is 1.5% and 0.35 ATR below the price. That is inside normal daily noise, and today's low was 21.90. Your fallback reference, the 20.85 band, has fallen every session since 22 Sept (26.47 to 20.85). It is a moving target, not a floor, and nothing below 21.90 is structural. "Early and small" is an honest admission that the tape is not on your side.

Answering your questions¶

1. What path gets to -10% to -15%? One more quarter like Q2 (-7% revenue QoQ) is nearly there. Alternatively, gold 5% lower (~$3,900 from the unverified $4,107) plus ~5% less volume from the guidance cut gives about -10%. Polymarket gives 28% to a touch of $3,900 in October alone, with the skew downward. Costs stay flat because Q2 showed 90% flow-through. The caveat is that Q2's realized gold price isn't in the data. If it was below today's spot, there is cushion, and if it was above, the risk is larger.

2. Which row after a clean 28 Oct? Rows 1–2 on Q3, and I've said that hurts my case. But the row going forward is set by gold and the 2027 guide, not by the print. Even then you need the 8x to 10x re-rating to make money.

Bottom line¶

This is a high-quality balance sheet attached to a peak-margin, ~90%-decremental, 1.5-beta gold call. The multiple is falling, the tape is making lows, estimates haven't been cut, and the macro regime is tightening. Your margin of safety narrowed to a re-rating bet with symmetric payoffs.

What would change my mind: - Q3 unit costs flat or down despite lower volume, which would break the 90% flow-through. - Buybacks stepping up toward ~$350M or more a quarter. - Gold holding through the CPI and Fed calendar into 10 Dec. - Consensus EPS being cut while the stock holds. - A daily close above 25.27.

Caveats: Spot gold, the guidance date and today's bar are unverified. Q2's realized gold price, AISC, royalties and minorities are not in the data. The generalizations about cyclical price-leads-earnings and miner leverage to gold are not drawn from these tools. Tables are illustrative: flat costs, 28% tax. Bear Analyst: # Bear Rebuttal: KGC at $22.24

You've been straight about the weak spots, so I'll start with what you earned.

What I concede - The upside rows. I re-ran your extended table and every cell checks out. A table that stops at 0% on the upside isn't neutral. - Flat costs are slightly harsh. At the ~90% flow-through Q2 showed, the -10% row is about $2.29, not $2.24. That moves the 10x break-even from -10% to about -11.5%. It doesn't change the picture. - "Estimates haven't been cut." I can't verify it, so I'm withdrawing it as a fact. The narrower point stands. $2.78 is roughly Q2 annualized ($2.80–2.84), so whenever it was struck, it embeds no further step-down. UBS and Desjardins have trimmed targets. - Thin hike markets. They lower the precision. They don't flip the sign, because the hot CPI (3.7% vs 3.6%) and the yield headlines don't come from Polymarket. - Buyback policy timing. "Not yet in effect" fits the data. Q3 is the first test.

1. You've written down the price of my case, and it's the base case¶

You say $22.24 embeds an 11–20% EPS decline at 9–10x, "roughly one more Q2-sized step down." Check what that step is worth. Q2 revenue fell 7.0%, which at 90–100% flow-through is a 12–14% EPS hit. That leaves EPS near $2.40–2.44, so:

At 9x: about $22, which is flat.
At 10x: about $24, which is +8–10%.

The guidance cut covers 2026 and 2027 at two named mines, so it points the same way as that step. Its size is unknown, but I don't see it as a tail risk. A stock that prices the base case is fairly valued. That has been my claim since round one: not a collapse, and not a bargain.

2. Your "thesis holds" line pays nothing at your own multiple¶

Mapping your Q3 thresholds onto your table:

Q3 gross margin	Revenue vs Q2 (flat costs)	Return at 8x	Return at 9x	Return at 10x
57.5% (Q2)	0%	0%	+13%	+25%
~55% (your "holds" line)	-5% to -6%	-10% to -12%	0% to +2%	+10% to +13%
~53% (your "breaks" line)	-10%	-19%	-9%	+1%

Your pass mark is the 9x break-even. The thesis only pays if Q3 beats the bar you set, or if the multiple goes past 9x. The 53–55% zone, which you didn't label, loses money at your own multiple.

3. The carry is real but small against the volatility¶

Carry vs range. Your table shows cash returns of 3.7–5.6% of market cap. One ATR is $0.96, or 4.3%. Today's session was -5.1%. A year of carry is about one day of range.
The "~5% retired" figure is the top row. In the -10% row, 50% of FCF less dividends is $0.96B, or 3.6% of market cap. That is today's pace ($910M TTM, ~3.5%), and it ran through a 41% drawdown without setting a floor. The policy holds returns flat in the scenarios where the stock loses money. It lifts them only where the stock is fine.

4. The staged plan buys the one part that has no edge¶

The first third is a coin flip. Your 28 Oct thresholds make the print a real test, so a third bought before it is a bet on the outcome. You also say volume is unlikely to surprise, in which case a clean print pays little. Either way, waiting costs little.
The thesis stop sits behind the gap. It is evaluated after the print, so it doesn't protect the first third from the event it was designed around.
The sizing anchor is too tight. You size for a gap to 20.85 (-6%). This stock printed -11.6% and -5.1% in three weeks, and -11.6% from here is $19.66. The 20.85 band has fallen every session since 22 Sept and will be lower by 28 Oct.

5. Your questions¶

1. Which Q3 gross margin proves me right or wrong? - Right: below ~55%, which is your own line. Even at 9x you make nothing there. - Wrong: at 57.5% or better, with FCF of at least $735M and buybacks of at least ~$300M. - In between: no edge either way.

One honest caution. Q3 covers July–September, and the stock rallied from 23.57 to 33.48 in August. That suggests realized prices may have been decent, though Q2 and Q3 realized gold aren't in the data. A clean Q3 is plausible and backward-looking. I'd judge the print by the 2027 guide and unit-cost commentary, not trailing margin.

2. What's fair at flat revenue? Cheap. That's the 0% row, and I've said so since round one. The 8x isn't my fair multiple for a flat world. It is the market's weighting on how long flat lasts. You offered three ways to stop the multiple falling: - Buyback accretion is a per-share effect and doesn't lift revenue. - The print is low-surprise on volume, in your own words. - Gold stabilizing is the only one that touches revenue. It has the options skew pointing down (54% touch $4,000, 28% touch $3,900) and a hawkish macro regime against it.

So the thesis is a gold call carried by a good balance sheet, and I'd rather not make it with a fully bearish stack against me.

Bottom line¶

We agree on the balance sheet, the lumpy capex, the tax normalization, the chart and the arithmetic. We disagree on how likely the top rows are, and on whether to pay for the option before the information arrives. Your own words put the downside case at "roughly fair, with the carry to show for it." Your pass line pays about zero at 9x, and a year of carry is about one ATR. For a 1.52-beta stock four trading weeks from a binary print, I don't think that is enough to pay for being early.

My stance: avoid or underweight now, and revisit after 28 Oct. If the print clears, you're buying with more information at a modestly higher price, and the cost of that is small next to the downside it avoids.

What would change my mind: - Q3 gross margin of at least 57%, FCF of at least $735M and buybacks of ~$300M or more. - An unchanged 2027 volume guide and flat or lower unit costs. - Gold holding above $4,000 through the CPI and Fed calendar. - A daily close above 25.27. - Consensus cuts with the stock holding.

Caveats: - Spot gold, the guidance date and today's bar are unverified. - Realized gold in Q2 and Q3, AISC, royalties and minorities aren't in the data. - The 90% flow-through comes from one quarter, and the sequence ranges from 28% to 145%. - Tables are illustrative: flat costs unless stated, 28% tax, and the 9x multiple is your assumption, not a forecast. Bear Analyst: # Bear Closing Argument: KGC at $22.24

We now agree on the balance sheet, the arithmetic, the lumpy capex, the tax normalization and the Q3 test. What's left is narrow, so I'll take your concessions first and then answer your question.

What I concede - "Four trading weeks" was wrong. 14 to 28 October is ten sessions. - "Waiting is free insurance" was overstated. If the print is fairly priced, waiting avoids the bad outcome only by also skipping the good one. Waiting is worth something only if you have a view on drift, and I don't have a strong one. I'll say what I do have below. - The gold "downside skew" was mostly distance. I re-ran your random walk (22% vol, ~$4,107 spot) and got ~58% / 28% / 10% for the $4,000 / $3,900 / $3,800 touches, so your table checks out. The vol looks fitted to the strikes, so it describes the market rather than proving it. The 1–2% upside tail sits at the price floor of thin markets and carries no signal either. I withdraw "the skew points down" as evidence of drift. - One down quarter against three up is not a base case. The 9.2x on $2.42 is also correct arithmetic. - Carry versus ATR is not a risk measure. And buyback pace shouldn't be a precondition for the print test.

1. Your question: what do I pay after a clean print?¶

At +8% the stock is $24.02. That is 8.6x the $2.78 forward EPS and about 8.4x TTM, using ~$2.85 with a $0.70 Q3 replacing the $0.48 Q3'25. That is no more expensive than today's trailing multiple, so on a clean print I'd be a buyer there.

Entry rule: the clean row of your table (gross margin ≥57%, FCF ≥$735M, flat or lower unit costs, 2027 guide unchanged), plus the stock holding above its 10 EMA (23.63 today, and it will have moved).
Ceiling: about 9x forward, or ~$25. That sits next to the 25.27 daily SuperTrend flip, so my price ceiling and my tape trigger roughly coincide.
What I'm paying: up to ~8% for information. That is the cost of my view, and I'm not calling it free.

2. The first third has no edge inside the window¶

You say a clean print is "not a surprise" on volume. That means a clean print shouldn't produce an 8% pop either, and an 8% pop would require the market to be wrong about P(clean). That is the same drift disagreement from the other side.

Over ten sessions: - Carry is ~0.1–0.2% (5.6% × 10/252 at best, ~3.6% in the weaker row). - Daily range is ~4.3%. - The print is zero-mean by your own argument.

That makes the first third a roughly zero-EV, high-variance position. We agree on its sizing, and you call it a rounding error. My objection isn't that earnings are near. It is that the only information flowing in the window is the tape: all three SuperTrend tiers down, ADX 36.8, and a lower band that has fallen every session since 22 Sept. That information points the wrong way.

3. What 28 Oct can't resolve¶

Treating the print as the decision point oversells it: - Q3 is backward-looking. It covers July–September, including the August rally, and the realized gold price is not in our data. A clean Q3 is plausible, and you've called it more likely than not. - Gold sets revenue. After a clean print the stock is still a 1.52-beta gold call. The print tells us costs and volume, and nothing about the gold path or 2027 revenue. - Forward P/E on possibly stale consensus is weakest at turning points. $22.24 is 8.0x on $2.78 and 9.2x on $2.42, and both describe the same price. I can't verify revision history. I do see two broker target cuts and a $2.78 that equals Q2 annualized, so I'd expect the EPS estimate to move toward the price rather than the reverse. That is an expectation, not a fact. - The multiple de-rated before. It fell from 10.5x on 23 Sept to 8.5x with reported EPS unchanged. Your 9.2x floor is a judgment about a net-cash, 37%-ROE producer. It is reasonable, but nothing in the data enforces it.

4. Where my price discipline sits¶

My base case is $2.42 EPS. At 9x that is ~$21.8 and at 10x ~$24.2, so $22.24 is fair, not cheap. If the stock fell to ~$20 before the print with nothing fundamental changing, my own base case would be 8.3x, and I'd take that more seriously. So my objection is to buying at a fair price into an unresolved event with the tape against it. It is not to owning KGC.

Bottom line¶

Our plans are now the same except for one-third of a position for ten sessions. I think that tranche earns nothing in expectation, and your own sizing logic ("a rounding error") agrees. The gold call, the 2027 volumes and the multiple are not resolved by the 28 Oct print, so even a clean print supports a sized and staged position, not a conviction one.

My stance: avoid or underweight until 28 Oct, then act on the table.

Q3 result	Action
Clean: GM ≥57%, FCF ≥$735M, unit costs flat or lower, 2027 unchanged	Start buying up to ~$25; add on a 25.27 daily close
GM 53–57%	No edge; stay out
GM <53%, FCF <$575M, unit costs up, or 2027 cut further	Stay out; 20.85 is a moving band and not a floor

What would change my mind before the print: - A price near $20 with no fundamental change. - Evidence that consensus has been cut and the stock held. - Gold holding above $4,000 through the CPI and Fed calendar.

Caveats: - Spot gold, the guidance date and today's bar are unverified, and I haven't checked whether an FOMC decision lands the same week as the print. - Realized gold, AISC, royalties and the size of the guidance cut aren't in the data. - The 90% flow-through comes from one quarter, and the range across quarters is 28–145%. - All tables and multiples are illustrative, not forecasts. Bear Analyst: # Bear Final Rebuttal: KGC at $22.24

We agree on the facts, the arithmetic and the Q3 decision table. What's left is whether to hold a small starter through ten sessions with no edge either way. I'll try to say what that disagreement is worth.

What I concede - The tape is not a drift signal. Your July comparison holds. The same lower-highs, lower-lows description applied at the 20 July close of 22.50, and the stock then gained 49% to 33.48. I'll stop using the chart as a reason to wait. - ADX isn't only the 24 Sept gap. It fell to 34.64 by 13 Oct and rose to 36.83 today, after the second gap day. That is a variance point (-11.6% and -5.1% in three weeks), not a direction call. - My ceiling is $25, which is +12.4%. My 8% example understated what my own rule can cost, and you should hold me to the ceiling. - I narrowed some arguments and withdrew others. I withdrew capex-ramp and gold-skew-as-drift. I narrowed flat costs to ~90% flow-through, which is one quarter in a 28–145% range. Net cash is still positive after the haircuts, and I never made a solvency argument. - The FOMC date. Your recollection of a 27–28 Oct meeting matches mine, but neither of us has it from the tools. I treat it as unverified.

1. The 12% is a tranche cost, and it cuts both ways¶

The 12% applies only to the starter. At one-third weight, a rally to my $25 ceiling costs about 4% of the intended full position (12.4 ÷ 3). The gap you sized for, to $19.66 (-11.6%), costs the starter about 3.9% of the position, and in that case I'm buying about 12% lower than you did. You can't call the starter a rounding error and also treat its 12% as a large cost. The gain and the loss are symmetric, which is the zero-drift point I conceded last round.

Your "more likely than not" on a clean print adds a wrinkle. If the market agrees, a clean print is mostly in the price, so the typical reaction is small. A break (gross margin under ~53%) moves the stock much more. That is a zero-EV bet by construction, but it pays a small gain most of the time and a large loss occasionally. I'd rather not hold a starter through that shape. It also means a +8–12% pop is not the typical clean-print outcome, so my expected cost of waiting is lower than the headline 12%.

2. The "favorable shape" is the multiple assumption¶

Here are your own three rows against the multiples in play:

Multiple	Flat ($2.78)	Base ($2.42)	-10% ($2.24)	Unweighted avg
8x	0%	-13%	-19%	-11%
9x	+13%	-2%	-9%	~0%
10x	+25%	+9%	+1%	+11.5%

At 9x, which is your own midpoint between 8.0x and 9.9x, the three rows average about zero. The whole edge is whether the multiple ends above or below 9x. We agree that nothing in the data enforces 9.2x, 8x or 10x. Carry adds roughly 3.6–4.1% a year. If you add last round's +5% and +10% rows, the averages rise. Whether those rows deserve weight is the gold call.

That also bears on "if revenue holds, it's cheap by 13–25%." The flat row needs realized gold to offset ounces lost to the 2026–27 guidance cut, and the size of that cut isn't in our data. Spot gold, unverified, fell about 1% today and the hike markets moved the wrong way. I'm not calling flat unlikely. But the scenario that makes the stock cheap is the one that needs gold or volumes to cooperate, and the scenario you agree is fair doesn't.

3. What 28 Oct can and can't settle¶

A clean print resolves the cost half. That means unit costs, capex and the 2027 guide not being cut again. It doesn't resolve gold. I agree with you on that, and it's why I call this a staged position and not a conviction one.
A possible FOMC on the same day contaminates the reaction. If the meeting is 27–28 Oct and the print lands that day, the 28 Oct move mixes the print with a rates decision in a market pricing 86% for another hike (thin volume). I'd judge the print on the 29–30 Oct closes, not the reaction day. Waiting would then resolve two events, not one. That applies to both our post-print entries.
A backward-looking Q3 covers the August rally. It tells us little about Q4 gold, so the 2027 commentary matters more than trailing margin.

Bottom line¶

The plans differ by one-third of a position for ten sessions, and the expected value of that tranche is about zero in both directions. I'd hold off on it because of its negative skew and a distribution that has gapped twice in three weeks. Your own stress sizing of -11.6% puts your starter's worst case at the price where I would start buying.

This is not a short. It is a refusal to pay a fair price (9.2x on my base case) for an unresolved cost question, while the multiple has de-rated from 9.9x to 8.0x in three weeks and consensus EPS ($2.78) is roughly Q2 annualized. I can't verify revisions, so I treat that as a risk and not a fact.

My rules: - Clean print: gross margin ≥57%, FCF ≥$735M, flat or lower unit costs, 2027 guide not cut further, confirmed on the 29–30 Oct closes. Start buying with a ceiling near $25, which is 9.0x forward and about 10x my base case. Add on a daily close above 25.27. - Gross margin 53–57%: no edge, so stay out. - Break: gross margin <53%, FCF <$575M, unit costs up, or a deeper 2027 cut. Stay out. The 20.85 band falls daily and is not a floor. - Before the print: a price near $20 with no fundamental change (8.3x on my $2.42) would make me start.

What would change my mind: consensus cuts with the stock holding, gold holding above ~$4,000 through the CPI and Fed calendar, or a 2027 guide that turns out to be conservative.

Caveats: - Spot gold, the guidance date, the FOMC date and today's bar are unverified. - Realized gold, AISC, royalties and the size of the guidance cut aren't in the data. - The 90% flow-through is one quarter in a 28–145% range. - All tables are illustrative arithmetic, not forecasts, and the unweighted averages are not probability-weighted.

Research Manager¶

Recommendation: Overweight

Rationale: After five rounds the two sides agree on nearly every fact. At $22.24, KGC trades at 8.0x forward EPS of $2.78 and 8.5x TTM, with an ~11% FCF yield and 37% ROE. Operating cash flow has run at ~$1.14B a quarter. Net cash is ~$1.9B on the headline figure and ~$0.35B after the $587M tax payable and ~$976M of provisions. The question is whether that price pays you for the risk.

The bear's best points still stand: - Consensus $2.78 is roughly Q2 annualized, so it embeds no step-down. That holds even though management cut 2026–27 production guidance at La Coipa and Round Mountain. - In Q2, about 90% of lost revenue fell through to operating income, so operating leverage cuts both ways. - Buybacks have drifted down ($265M, $250M, $230M), so the 50%-of-FCF policy isn't visible yet. - The multiple de-rated from ~9.9x to 8.0x forward in three weeks with no change in reported numbers. Nothing in the data enforces a floor. - The tape is fully bearish: all SuperTrend tiers down, ADX 36.8, close below the July low. - The gold path and 2027 volumes won't be settled by the 28 Oct print.

The bull's best points: - Take the bear's own base case of one more Q2-sized step down, about $2.42 EPS. The stock is then 9.2x, which is fair, not expensive. - Flat revenue makes it 13–25% cheap at 9–10x. - A double-digit loss needs both a deeper revenue miss and a sub-9x multiple on a net-cash, high-ROE producer. - The balance sheet removes financing and dilution risk, so the buyback can run at lows.

What decided it was how far the bear retreated. He withdrew the capex-ramp argument and the claim that gold skew points down; it was distance from spot, not drift. He dropped the tape as a drift signal, narrowed the flat-cost argument, and withdrew 'estimates haven't been cut' as a fact. He ended by saying this is not a short. He would start buying near $20 before the print, and up to ~$25 (9x forward) after a clean print.

So both sides want to own KGC at or near these levels. They differ only on a pre-print tranche whose expected value both call roughly zero. That is a timing and variance problem, best handled with sizing and staging rather than avoidance. The bear's sharpest surviving point is about the shape of the print reaction: a clean print is likely mostly priced, while a break would move the stock much more. Add two gap days of -11.6% and -5.1% in three weeks and a possible FOMC around 27–28 Oct (unverified). Together those argue for a smaller starter than the bull's one-third.

Why not Buy: the 9x scenario average is about zero, gold and 2027 are unresolved, the size of the guidance cut is unknown, and the trend is down.

Why not Hold: the valuation asymmetry, the net-cash balance sheet and both analysts' entry rules all point to accumulating from here.

Missing data that limits conviction: - Spot gold (~$4,107) is single-source and unverified. - The guidance-cut date and size are unconfirmed. - Realized gold prices, AISC and royalties aren't in the data. - Consensus revision history isn't available. - The 10-year yield is missing because the FRED pull failed. - The FOMC date is unconfirmed, and today's bar may be provisional.

Strategic Actions: Target position: build toward 1.0x a standard allocation, staged. Allow up to 1.25x only after both fundamental and technical confirmation.

1) Pre-print starter, now: buy ~0.25x standard allocation in the $21.90–22.40 area using limit orders. Size it so a repeat -11.6% gap (~$19.66) costs no more than ~0.3% of the portfolio. Do not rely on a tight price stop. The 21.90 level is only 0.35 ATR away, and the 20.85 lower band falls daily, so position size is the risk control.

2) Opportunistic add before the print: if KGC trades near $20 with no new fundamental news, add another ~0.25x. Both analysts flagged ~8.3x on the $2.42 base case as attractive. Cap total pre-print exposure at 0.5x.

3) 28 Oct Q3 print: judge it on the 29–30 Oct closes, not the reaction day, in case an FOMC decision lands the same week (unverified). Use this table: - CLEAN (gross margin ≥57%, FCF ≥$735M, unit costs flat or lower, 2027 guide not cut further): add ~0.35–0.4x, paying up to ~$25 (≈9x forward). - NO EDGE (gross margin 53–57%): hold the starter and do not add. - BREAK (gross margin <53%, FCF <$575M, unit costs up despite lower volume, or a deeper 2027 cut): exit the full position and reassess.

4) Technical add: on a daily close above 25.27 (the daily SuperTrend flip), add the remainder to reach 1.0x. Extend toward 1.25x only if quarterly buybacks step up to ≥$300M and gold holds above ~$4,000 through the CPI and Fed calendar into mid-December.

5) Thesis-level exits, regardless of price: cut to zero or a token position if gold holds below ~$3,900, if buybacks keep falling after the print despite the 50%-of-FCF policy, or if consensus EPS is cut sharply and the stock fails to hold.

6) Monitoring: track spot gold daily (current level unverified), Fed and CPI headlines, and the 2027 guidance commentary on the call. Confirm the FOMC and earnings dates before 27 Oct. The trader and portfolio manager should map these tranche sizes onto actual holdings. If KGC is already held at or above 0.5x standard, skip the pre-print buys and let the 28 Oct table drive any adds.

III. Trading Team Plan¶

Trader¶

Action: Buy

Reasoning: The plan's Overweight call maps to a Buy. At 22.24 KGC trades at about 8.0x forward EPS with an ~11% FCF yield, 37% ROE and net cash. Even the bear's base case of one more Q2-sized step down (about $2.42 EPS) leaves it near 9.2x, and both sides say they want to own it near these levels. The tape is fully bearish: all three SuperTrend tiers are down, ADX is 36.8, and today's close is the lowest in the 252-bar window. RSI is 29 and the Z-score is only -1.3, so no reversal is confirmed. A staged, small starter is the right way to handle the 28 Oct print risk, rather than a full-size Buy or a Hold. The 21.90 low is only about 0.35 ATR (ATR 0.96) from the close, and the 20.85 lower band falls daily, so position size is the main risk control and the stop is a wide disaster level. The gap days of -11.6% and -5.1% show that tight stops can be gapped through. Gold (~$4,107), the guidance-cut size, the FOMC date and today's possibly provisional bar are all unverified, which is why the starter is only ~0.25x.

Entry Price: 22.1

Stop Loss: 19.6

Position Sizing: Starter ~0.25x a standard allocation via limit orders in the 21.90-22.40 area. Size it so a repeat -11.6% gap (to ~19.66) costs no more than ~0.3% of the portfolio. Add another ~0.25x near $20 only if there is no new fundamental news, and cap pre-print exposure at 0.5x. After the 28 Oct print, judge it on the 29-30 Oct closes. If it is clean (gross margin >=57%, FCF >=$735M, 2027 guide not cut further), add ~0.35-0.4x, paying up to ~$25. If it breaks (gross margin <53%, FCF <$575M, or a deeper 2027 cut), exit fully. Add the remainder to reach 1.0x on a daily close above 25.27. If the book already holds 0.5x or more, skip the pre-print buys.

FINAL TRANSACTION PROPOSAL: BUY

IV. Risk Management Team Decision¶

Aggressive Analyst¶

Aggressive Analyst: I'll open, since nobody else has spoken yet, and I'll answer the objections I expect.

The conservative case will be that this is a falling knife. All three SuperTrend tiers are down, ADX is 36.8, we're at a 252-bar closing low, RSI is 29 with no bullish divergence, and the Z-score is only -1.3, so the stock isn't even statistically stretched. I concede every one of those facts. But they describe what has already happened. The stock has fallen 41% from the January close, including gaps of -11.6% on 24 September and -5.1% today. A trend-following system would have you buying only after the daily SuperTrend flips on a close above 25.27, which is about 14% above our 22.10 entry. That flip would leave the weekly and monthly tiers still pointing down, so you'd pay 14% more for a confirmation that confirms very little. The stop is 11.3% below entry, and the first real upside markers, the 50 SMA at 27.59 and UBS's $28 target, are 25-27% above. That's better than 2:1 on a position sized so a repeat gap costs about 0.3% of the portfolio.

The valuation is what pays us for taking the risk. KGC trades at about 8x forward earnings, 4.5x EV/EBITDA, with an 11% FCF yield, 37% ROE, and roughly $1.9B of net cash after paying down $502M of debt. Operating cash flow has held near $1.14B for three straight quarters. The bear's own base case, another Q2-sized step down to about $2.42 EPS, puts the stock at 9.2x. At 8x forward, or 9x on the bear's number, the market is already pricing in a lot of bad news. If the multiple recovers to 10x on that same bear EPS, you're at 24, and 10x on consensus is nearly 28. The trade doesn't need a heroic recovery.

On earnings quality, the neutral side will say net income was propped up by the tax rate dropping from 35% to 28%, pre-tax income is down two quarters in a row, capex jumped 45%, and cash taxes are heavy. All fair. But operating cash flow is after those cash taxes. Q1 and Q2 paid $449M and $327M and OCF still printed about $1.14B. The FCF yield already carries that drag. The $587M of tax payable is about 2% of market cap against $1.9B of net cash. The Q2 FCF dip came from capex, not from collapsing operations.

On macro, I'm not going to pretend it's friendly. Polymarket puts an 86% chance on another hike, 97% on no cuts, and the touch markets lean toward gold dipping to $3,900-$4,000. But gold is about $4,107 by an unverified post, and even in the thin touch markets only 7-10% sits on $3,700-$3,800. Meanwhile there's a convex piece the bears are ignoring: global bond stress, "debt crisis chatter," oil around $103, and a 16% Iran-invasion tail. Any of those flips the narrative for gold equities quickly, and we'd rather already own the stock when that happens. The sell-side hasn't capitulated either, with UBS and Desjardins trimming targets but holding Buy ratings.

On the 28 October print, the conservative will say wait. But waiting means buying after the move, and the plan already handles the event risk. Pre-print exposure is capped at 0.5x. The post-print rules are explicit: add if gross margin is 57% or better, FCF is at least $735M, and the 2027 guide isn't cut again. Exit completely if gross margin is under 53%, FCF is under $575M, or the guide is cut deeper. That's defined risk, not blind faith. The July-to-August precedent shows what happens when sentiment turns. The stock went from 22.50 to 33.48, about +49%, and from 22.38 to 28.23 in late 2025. I'll give the bears that today's close is below the July low, so I'm not calling this a clean double bottom. But the pattern shows this tape can reverse violently, and reversals don't announce themselves.

To the neutral analyst who wants a Hold: Hold has a cost. You'd sit out an 11% FCF yield on a net-cash balance sheet while the bear case, the bull case, and presumably you all say this is a price you'd like to own. The disagreement is about timing, and a staged 0.25x starter is how you handle timing uncertainty. It's small enough to survive a gap through the stop, and it leaves dry powder near $20.

I'm also discounting the sentiment data, as you would. It's two accounts and a thin sample, and it doesn't change my view in either direction. I'm not blind to the unknowns: gold's level, the size of the guidance cut, the FOMC date, and whether today's bar is provisional. That's why this is a starter and not a full position. The market is offering a profitable, cash-rich producer at roughly 8-9x earnings after a 41% drawdown, and I'd rather own a small, defined-risk piece of that than wait for confirmation that arrives 14% higher. Buy. Aggressive Analyst: Conservative, Neutral, you've both landed some hits, so I'll concede those first and then say where I think you're wrong.

Neutral is right that "wait for the flip at 25.27 and pay 14% more" was a strawman. The real alternative is a starter after the print or after a reclaim of 23.63. Neutral is also right that 2:1 only works if the stock gets to the 50 SMA, and that I can't use the bear EPS as my floor and consensus as my payoff. And the $20 add is the weakest part of the plan as written. I'd trade it for Neutral's version, a small add on a daily close above 23.63 that holds 23.44. I'd also measure the print against consensus and the guide instead of Q2's numbers, and define the middle zone as hold, add nothing, and let the 29-30 October closes decide. Those are better rules. I'm also dropping the convexity argument as a thesis. Hot CPI, a bond selloff and $103 oil all showed up and gold still fell, and Trump took some air out of the Iran tail. It's a free option that only pays if you own the stock, not a reason to buy.

Now where I disagree. The payoff is a distribution, not a single scenario. Conservative, you keep pricing the trade at 10x on the bear EPS, but the stock traded at 33.48 in August, which is north of 12x trailing earnings. Even 12x on the bear's $2.42 is about $29. Ten times is my conservative multiple, not my base case. And the bear EPS is already harsher than a repeat of Q2. Neutral's math puts a repeat at about $2.50. For a 10% price shock to hit your 17% gross profit stress, you need gold near $3,700, which the thin markets give 7%. If EBITDA fell 25%, the stock would still be at roughly 6x EBITDA with an FCF yield around 8.5%, using the vendor numbers. That's a lot of bad news to price in at 22.

The Q3 print also isn't a gold-price event the way you're treating it. The quarter closed on September 30, so a dip toward $3,900 in October can't change the realized prices being reported on the 28^th. It can hit the multiple, and it can hit the Q4 outlook and cost commentary, but those are guidance risks, not a repeat of the 11.6% gap. The guidance cut that matches that gap is, as Neutral inferred, probably already in the price. The $2.78 forward EPS is also below the annualized run rate of the last two quarters, $2.80 to $2.84, so consensus isn't sitting on peak numbers. And UBS trimmed its target about 7% after a 12% drop in the stock. That's not capitulation, and I won't claim it is. It does mean estimates haven't collapsed.

On earnings quality, Neutral closed this one for me. The tax payable doubled because cash taxes were tiny in the second half of 2025, and in the first half of 2026 cash taxes roughly equalled the provision. So Q2's $735M of FCF is already fully taxed, and the $587M catch-up is about 49 cents a share, around 2% of the price. Conservative, comparing it to a quarter's FCF is the wrong denominator. The vendor quirk is real, so I hold it loosely, but it cuts my way.

On the technicals, I'll give you the fact that RSI has no bullish divergence and the trend tools dominate. But look at what the ADX is measuring. It was 4 to 5 on September 23. The 36.8 comes from two gap days, not a steady grind. It peaked at 39.56 on October 8 and was rolling over before today. Between October 1 and October 13, MACD plateaued and MFI printed its lows at 0.17, above today's 0.25 only because today's price is lower. That's not a bounce signal. It does say the selling was not accelerating until one more gap bar, and that bar might be provisional.

Conservative, Neutral's point about your trend filter stands. You'd start buying on October 29 or 30 with all three SuperTrend tiers still down. That's an event filter, and a good one, but you can't then say the trend forbids a starter. Also, a daily flip on the way up in July would by construction have come well above 22.50, so strict trend-following would have bought the August rally late.

The sequencing argument is where I hold firm. Waiting doesn't remove print risk, it swaps it for the risk of a good print you then chase, and Neutral is right that this stock can move 8 to 12% either way. I'll also concede that the 11% FCF yield is not what a holder collects. The cash returned is about 4.1%, so two weeks of carry is worth roughly 0.15%. Carry was never my reason to buy. The cost of waiting is a possible gap up against a small position.

On size, the gap between Neutral's 0.15x and the trader's 0.25x is about a tenth of a percent of the book in the repeat-gap case, 0.3% against roughly 0.18%. The upside difference is similarly small. That's an argument about how to sleep, not about whether to own it. If the downside is that contained, the conservative case for sitting out entirely looks strained. At roughly a 2.5% position, a move to 27.6 earns about 0.6% of the book, and a repeat gap through the stop costs about 0.3%.

Verifying first is fine. Check that the bar is final, check spot gold, and check the guidance date. Those take minutes, not two weeks. If any of them comes back worse than assumed, I'd cut the starter, and I'd also check what gold has done since January, as Neutral asked. If you already hold 0.5x or more, don't add before the print.

So my answer is still Buy, with the $20 add replaced by Neutral's reclaim trigger. At 8 to 9x earnings, net cash and a 41% drawdown, a small defined-risk position is worth owning before the print, and the cost if I'm wrong is a few tenths of a percent. Aggressive Analyst: Neutral, the scale-up point is the best thing either of you said, and I'm taking it. The plan as written walks from 0.25x to 1.0x with the stop still at 19.6. An add near 25.27 is then about 22% above that stop, and if a full position is 10% of the book, that's roughly 2.2% at risk. We've spent three rounds on a 0.2% to 0.3% problem and left a 2% one untouched. My fix is risk-based sizing instead of a share-count ladder. Every add gets its own stop, ratcheted under the post-print low or the add-day low, and each is sized so a stop-out costs 0.3% to 0.5% of the book. I'll also give you the last third. With the weekly and monthly tiers still down and ADX at 36.8, a close above 25.27 only flips the daily, so full size waits for something like a reclaim of the 50 SMA near 27.59.

Conservative, you've earned several things. There's no pre-print add. I'd stop calling 19.6 a stop and treat it as the level where the thesis is wrong, reviewed on a close, because a resting order gets gapped anyway. The 0.3% budget should cover the book's whole gold-beta sleeve, not just this line. You're also right that a forward EPS of $2.78 against a $2.80 to $2.84 run rate means consensus hasn't rebased much, and right on the FCF math. With capex fixed, a 25% drop in operating cash flow takes about a third off free cash flow, so the yield lands near 7.5%, not 8.5%.

But look at what that stress requires. On Q2 numbers, a 25% hit to operating cash flow needs realized prices down roughly 17% to 18%, which puts gold in the mid-$3,000s. That's my arithmetic and it ignores hedges and royalties. The thin touch markets give 7% to $3,700. So your stress case is a tail, and even there you own a 7.5% FCF yield with about $1.9B of net cash, roughly 7% of the market cap. I won't call that a free lunch, but it isn't a peak-cycle illusion either. Neutral's 8x to 11x range on $2.42 to $2.78 gives about 19 to 31, centered near 25. That's roughly 13% down to 38% up around 22.24, with a center about 12% above. That's a reasonable edge for a small position, and it's all I'm claiming.

On the print, I agree the sign isn't established, and I can't prove it's positive any more than you can prove it's negative. Three things make me doubt the negative skew. First, if the headline "fell 12%" is the 24 September gap, as the match with -11.6% suggests, the guidance reset came six days before the quarter closed. Management knew Q3 production when it reset 2026 and 2027, and people resetting an outlook have every reason to set a bar they can clear. That's inference, and the news tool says the timing is unconfirmed, so check it. Second, the return target is now 50% of FCF, while Q2 returned about 38%. Closing that gap is worth somewhere around $350M to $450M a year, or 1.4 to 1.7 points of yield, though I can't say the target is defined the way the vendor defines FCF. Third, the gold hit is already in the price. The stock is about 19% below the pre-gap close of 27.62, today's drop included, while the quarter being reported hasn't changed. A stock that has fallen that far on forward worries doesn't need a beat to bounce. It needs the absence of a second cut.

Even if the print is a coin flip, that supports the starter. A good print with a starter in hand is roughly +10% on a small line, and a bad one is roughly -10%. Waiting swaps that for a cleaner entry about 10% higher. Information isn't free, and you pay for it in price.

On today's gap, I'll accept the peer test as a hard gate. A 1% gold move showing up as 5% in a 1.52-beta miner on a hot-CPI risk-off day isn't strange, since gross profit already moves about 1.7 times as much as price at Q2 leverage. But if KGC lagged a basket of its peers, such as NEM, AEM or GDX, by more than about three points, wait until someone can explain why. If the bar turns out to be provisional, the limits in the 21.90 to 22.40 band mean we only fill inside the range we've already underwritten.

Where I come out is a Buy, smaller and conditional. Verify the bar, the peer move, spot gold against where it was in January, the guidance timing and the Q3 consensus. If those pass and you're flat, start at 0.15x on limits. I'd stretch to 0.25x only if you hold no other gold beta, because the extra 0.1x costs about a tenth of a percent of the book. Don't add before the print. After it, judge against consensus and the guide, and if you can't find consensus, use Q2's numbers as the bar. A clean print gets risk-sized adds with ratcheted stops, the middle zone means hold and add nothing, and a broken print means exit.

We all agree this is a price worth owning over six to twelve months. The only question is whether to put a first slice on before an event none of us can sign. At this size, being wrong costs a few tenths of a percent, and waiting means paying up for certainty the market will charge us for. Aggressive Analyst: Conservative, your sizing correction is the best thing said in this debate, and it changes my plan. Sizing off the stop is wrong on a tape that has gapped through two levels in three weeks, so every tranche gets sized on a roughly 12% gap loss, and the cap is the sleeve's loss budget divided by 0.12. Your own ceiling of 2.5 to 4% of the book is also about what the trader's original 0.25x starter implied (0.3% over 11.6%). The damage in the original plan was the stacking: the 0.5x pre-print cap, the $20 add and the walk to 1.0x. I've given up all three. I'm also taking 0.15x instead of stretching, because it leaves room in the budget for a post-print tranche. Neutral is right that the stretch gains about what it risks. And 19.6 is where the thesis gets reviewed on a close, not a stop that will fill.

I'll also stop calling the 8x to 11x range an expectancy. If I put six scenarios on a flat grid (7x and 8x on the bear $2.42, 10x on the bear, and 8x, 10x and 11x on the $2.78 consensus), the average is about 23.5, roughly 6% above here. That's a modest edge with a fat left tail. The 7x case gives about 17, which is 24% down, and that's worse than the 12% gap we sized for. Even there it's only about 4x EBITDA by my rough scaling, with $1.9B of net cash. I still can't call that a floor. But a modest edge with a fat tail is an argument for a small position, not for none, and 0.15x is that.

On the print, I'll use your logic against you. If management reset the outlook knowing Q3, analysts rebased Q3 afterward, so a weak Q3 is the consensus and an in-line print is the likeliest outcome. You said consensus outcomes don't produce 10% gaps. If that's right, the center of the distribution is a small move, and the 10% gap on the starter is the tail the budget already covers. I'll still concede the buyback trend. $265M, then $250M, then $230M is not a ramp. The 50% return target is an option that only counts if the 28^th shows it.

On waiting, I think we agree on more than the tone suggests. If the print is symmetric, holding through it has zero expected value and so does sitting out. What's left is the six-to-twelve-month valuation, and you've said that doesn't depend on entering this week. That's true, and it's why the cost of either choice is small, about 0.15% of the book. The tie-breaker is what the paper-thin edge buys. Waiting buys a post-print entry near 24.50, which is about 8.8x forward, so you pay roughly 10% of price for information. You also still carry the macro gap at the same 12%, as Neutral said, because the print doesn't remove it. I think the starter wins that trade if the gates pass, but only barely, and I won't pretend it's more.

On the peer test, you're right that it passes the sector-wide, rate-driven selloff, and that's exactly where correlation risk peaks. That's what the sleeve-level 12% accounting is for, and why "no other gold beta in the book" is a condition. A rate-driven sector selloff is also the kind of drawdown this balance sheet can absorb. Cash is $2.66B, debt/equity is 0.08x, and operating cash flow has held near $1.14B for three quarters. KGC would fall with the group, but nothing would break. I accept your Q3 average gold versus Q2 gate. It's the one input that tests whether I'm right that this is not a gold-price event, and nobody here has it.

Neutral's FOMC point also matches my recollection of the published calendar, which has the October meeting on the 27^th and 28^th. That's from memory and not in our data, so confirm it. If the decision lands the same day as the print, the 29^th and 30^th closes carry both events. That's another reason for no pre-print add and for judging the result on those closes.

So I'm still at Buy, in the smaller form we've converged on. If the bar is final, KGC hasn't lagged peers by more than about three points, spot gold and Q3 average gold check out, the guidance timing is confirmed, and the sleeve is otherwise empty, take 0.15x in one clip near the current price. Add nothing before the print. After it, judge the result against consensus and the guide, and add one tranche on a clean print, sized on the 12% gap and inside the sleeve budget. In the middle zone, hold and add nothing. If it breaks, exit. If any gate fails or can't be confirmed, wait, and accept the cost. If you already hold KGC or a lot of gold beta, don't add.

What separates me from Conservative now is one judgment. A profitable, net-cash producer at a 252-bar low and about 8x earnings is where the next leg of return gets made, and this is a defined, small way to be there. The rules cap what being wrong costs, and being right and absent costs about the same. Aggressive Analyst: Conservative, Neutral, most of what you each said last round is right, so I'll take those hits first.

Conservative, you caught me using the middle of my own distribution to shrink the starter's risk and then using the good tail to inflate the cost of waiting. Waiting only costs you in the good-print branch, and the 10% figure was a good-branch number. I withdraw it. You're also right about the grid. A 23.5 average is about 6% above the close, and with a beta of 1.52 and yields where the headlines say they are, that doesn't pay you for the risk. I'll stop calling it an edge. All it shows is that the price sits inside a wide range. And on the FOMC date, two of us repeating the same memory is one recollection, not two sources. It isn't in our data, so confirm it.

Neutral, you're right that Q3 average gold against Q2 and the date on the consensus number are print-day inputs, not starter gates. Consensus already knows where gold averaged, so neither tells you whether to put 1.5% of the book on this week. Four checks is a list someone will actually run. You're also right that a 22.00 to 22.40 limit contains today's close, so nobody should place it tonight on a bar that may be provisional.

Here is where I still disagree.

Conservative, your stale-consensus dilemma doesn't hurt the case. If the guidance cut was small in earnings terms, a 19% drawdown from 27.62 is an overreaction, and that's my argument. If the $2.78 is stale, the bear EPS of $2.42 is already 13% below it, and that's the number the whole grid uses. For stale consensus to hurt beyond what we've priced, true forward EPS has to be below $2.42, and nobody has shown evidence of that.

On the balance sheet, I agree the book's risk is the mark, not solvency. But cash went from $1.74B to $2.66B in two quarters, about 3.5% of market cap, while the market cap fell. That doesn't prove mispricing, because the market may be saying earnings have peaked and the cash build will stop. It does mean the discount to what the company holds widened while the company got richer. Net cash is about $1.59 a share, roughly 7% of the price. That's what a small long is for.

On the label, Hold with an option attached has a problem. If all the checks pass, we all agree this is worth owning over six to twelve months, and every post-print add assumes a long bias. A Hold headline reads as "don't buy", which is wrong for the case where the checks pass. Neutral's fix handles your headline-travel concern. Put the gates in the action sentence itself: up to 0.15x, one clip, only if the checks pass, otherwise wait. If that sentence can't survive being read without its conditions, rewrite it until it can.

The most useful thing Neutral said is that neither of the big gaps was an earnings day. I took my 8-to-12% print move from non-earnings gaps, and the real number is unmeasured. We've spent three rounds arguing over an unmeasured quantity, and pulling the last four earnings-day reactions takes a minute. If they're 3 to 5%, the starter's print risk is negligible and waiting buys nothing. If they're 8% or more, I'll wait with Conservative. I'd commit now to accepting whatever it shows.

I also accept the pre-committed exit. A close below 19.6 means selling all of it, because at 0.15x keeping half is a decision worth nothing. That level is 11.9% below the close, about the size of the gap we sized on, and the fill could be worse. That's why anyone already holding gold should stress the whole sleeve harder, and Neutral is right that 20 to 25% is a judgment, not data.

So here is my position.

Flat book that hasn't run the checks: wait.
Flat book where the checks pass: the bar is final, KGC is within about three points of NEM, AEM and GDX, the sleeve is otherwise empty, the print date and time and the FOMC date are confirmed, and earnings reactions are modest. In that case, buy up to 0.15x in one clip near the close. No ladder, no add before the print, no chasing, and stand aside if 21.90 trades through unfilled.
Already holding KGC or other gold: don't add.
After the print: judge it against a dated consensus and the guide. If it's clean, add one tranche sized on the 12% gap, inside the sleeve budget. In the middle zone, hold and add nothing. If it breaks, exit.

I'm still a Buy on direction. A profitable, net-cash producer at about 8x earnings and a 252-bar low is worth owning at a size where being wrong costs a couple of tenths of a percent. I'm not claiming more than that, and the trader's original ladder to 1.0x was the part of the plan that deserved to go.

Conservative Analyst¶

Conservative Analyst: I'll take your points in order, because the plan is more fragile than you've framed it.

You concede every technical fact and then say they "describe what has already happened." So does your valuation case. The 8x forward multiple rests on a $2.78 forward EPS that is only about 6% above trailing. That figure may not yet reflect the cut to 2026 and 2027 production guidance, and UBS and Desjardins are still trimming targets. The trend isn't just history either. ADX at 36.8 on a fresh 252-bar closing low with all three SuperTrend tiers down is the condition where continuation is the better bet. RSI at 29 with a Z-score of only -1.3 is oversold momentum without statistical stretch, which is not a compressed spring. The Bollinger lower band falls every day and is now 20.85.

On risk/reward, "better than 2:1" only works if the trade reaches 27.59 or 28, and to get there it has to clear the 10 EMA at 23.63, the mid-band at 24.88 and the daily SuperTrend at 25.27. Use your own bear-case math instead. Ten times $2.42 is about $24.20, only 9.5% above 22.10, against an 11.3% stop. In the scenario you asked us to underwrite, the trade is worse than 1:1. The stop is also a gap-risk level, not protection, and we've had two gaps in three weeks. Size is the only real control, and the second tranche near $20 undermines it. A buy at 20 with a stop at 19.6 sits 2% from its stop, which is under half an ATR, so a normal day could stop out the add. Nothing in the data supports $20 as a floor. There is no price below 21.90 in the whole year, so the only reference is a falling band. That is averaging down into a trend, not dry powder.

On valuation, 8x earnings, 37% ROE and a 52% operating margin are peak-cycle numbers, and cyclicals look cheapest at peak earnings. Operating leverage cuts both ways. Q2 cost of revenue was about $950M against $2.24B of revenue. If realized prices fell 10% with costs unchanged, gross profit would drop roughly 17%. The bear's $2.42 is a Q2-sized step down, so it is a base case, not a stress case. A gold-driven move would come on top of it. Your sell-side point also cuts the other way. Buy ratings held on $28 targets with the stock at $22 is a lagging indicator, not capitulation, and the sentiment work lists follow-on target cuts as a live risk.

On earnings quality, I accept that operating cash flow is after cash taxes, but two things still bother me. Pre-tax income fell 10.5% in Q2 while operating cash flow stayed flat at $1.14B, and I'd want to know what filled that gap. Income tax payable also doubled to $587M over the year, which is about 80% of a full quarter's free cash flow. Comparing it to market cap makes it look small. Unpaid tax helps reported operating cash flow now and gets paid later. The fundamentals report also notes a vendor quirk in the tax lines, so I wouldn't lean hard on the cash-tax figures.

On macro, I agree the gold touch markets are thin, so I won't lean on them. Even taken at face value, they don't support your convexity argument. The odds are 54% to touch $4,000 and 28% for $3,900, against 2% for $4,700. You say bond stress and debt-crisis chatter are the upside tail, but global yields are already surging, France is stressed, and gold still fell on a hot inflation print. The haven bid hasn't shown up. The Iran tail is 16%, and Trump just said no attack before the midterms, so that tail is shrinking. With a beta of 1.52 and the leverage above, gold drifting toward $3,900-$4,000 hits KGC harder than the metal. Ten trading days before earnings is not where I want to be long into that.

On the 28 October print, your post-print rules are sensible, but look at the thresholds. Adding at gross margin of 57% or better and FCF of at least $735M means matching Q2, which was 57.5% and $734.9M, in a quarter where margins already slipped 2.4 points. Exiting below 53% and $575M leaves a wide middle zone where the rules say nothing. A 55% margin with $650M of FCF is worse than Q2, not a disaster, and the stock stays in a downtrend. Your exit is also a post-gap exit, so the stop doesn't protect you from the print. Your own plan is willing to pay up to $25 after a clean print. The starter's entire edge over waiting is the difference between about 22 and wherever the stock trades after the print, on a quarter-size position. The same position carries the full downside of a bad print. Without a view on the print itself, that is a coin flip with a gap attached.

On the July-August precedent, 22.50 to 33.48 shows the tape is volatile in both directions. But today's close is below the July low, so the level that produced that rally has already failed once. You concede it's not a double bottom. The late-2025 bounce from 22.38 happened before the guidance cut and before the market priced an 86% chance of another hike. "Reversals don't announce themselves" is true, but continuations don't either, and a trend filter exists to keep us from fighting a strong trend on hope.

You also aren't comparing against an easy alternative. You frame the choice as buying now or waiting for a 14% higher daily flip, but the choice is really now versus after the print. Waiting two weeks gives up roughly 0.15% of shareholder yield, since the cash actually returned is about 4.1% a year, not the 11% FCF yield. The cost of being wrong is much larger. Even a modest recovery shows up in cheaper confirmations than 25.27, such as a reclaim and hold above the 23.44 gap origin and the 23.63 EMA.

My adjustment to the plan, in terms any book can apply:

If you're flat: stay flat until after the 28 Oct print and the 29-30 Oct closes. Then apply the trader's own thresholds, with the middle zone defined.
If you already hold KGC: don't add. Treat 19.6 as a gap-risk level, not a guarantee, and size for a drop worse than -11.6%.
Drop the $20 add unless there is new information and a defined stop well below it.
Treat the unverified inputs as reasons to wait, not to start small. Spot gold, the size of the guidance cut, the FOMC date and a possibly provisional bar are all unconfirmed, and two of them resolve within two weeks.

The bulls and bears may agree this is a price worth owning. We disagree about sequencing, and sequencing is the one risk we can fully control. I'll hear the neutral analyst out, but a Hold until the print is the risk-adjusted answer. Conservative Analyst: Both of you moved a lot, so I'll start with what I accept.

Aggressive, you've dropped the $20 add, the convexity thesis and the "wait for 25.27" strawman, and you've admitted the 2:1 only works if the stock reaches the 50 SMA. Neutral, you've shrunk the starter. I also accept that my rule is an event filter, not a trend filter. The trend tools tell me not to be early, and the print tells me when the information arrives. I accept that the tax-payable story is the most likely explanation, though it rests on a vendor tax line the report itself flags as mis-mapped, so I'd hold it loosely. And I accept that October gold can't change Q3 realized prices, and that two weeks of carry is worth about 0.15%.

That last point is where I'd push hardest, though. If Q3 revenue is mostly observable because the market knows where gold traded, the surprises left are costs, capex, production and the outlook. Those are the places this company has disappointed. In Q2, revenue fell 7% while cost of revenue fell 1.7%, and capex jumped 45%. The 24 September gap came from a production guidance cut, not realized prices. Zacks is already asking about unit-cost margin risk for 2026. The stock also trades on forward gold, so a clean backward-looking quarter reported with gold near $3,900 isn't much of a catalyst. A good gap up needs a good print and cooperative gold. A bad gap needs only one of them. You're both treating the print as a symmetric 8 to 12% coin flip, and I think its skew is negative. That's inference, but it's inference from the cost and capex lines.

On "the guidance cut is already priced," forward EPS of $2.78 against a run rate of $2.80 to $2.84 is a 1 to 2% haircut. For a company that cut production outlook for two years, with pre-tax income down 10.5% last quarter, that assumes peak earnings hold. It isn't conservative. The stock is down about 19% from the close before the gap, and UBS trimmed its target 7%. Lagging targets are not capitulation. Aggressive, the 12x multiple at 33.48 belongs to a different regime. Since then the market has moved to an 86% chance of another hike, and the multiple has compressed by about a third. A move to 10x needs that regime to change, and you can't schedule it. Your 25% EBITDA stress is also a bit kind. Capex is fixed at roughly $1.37B a year, so if operating cash flow fell 25%, free cash flow would fall by about a third and the yield would be closer to 7.5% than 8.5%.

On the technicals, I don't think the ADX story helps you. It peaked at 39.56 on 8 October, eased to 34.64 yesterday, and turned back up to 36.83 today because the stock made a new low. MACD had plateaued and today it's drifting lower again. The MFI non-confirmation is mild, and the report says its scale is unverified. The selling really wasn't accelerating until this morning. This morning it did, on a 5% gap nobody here can explain. The only cause on offer is a gold move of about 1%, from a single unverified post, and that doesn't obviously explain 5% in the stock. I'd add "what caused today's gap" to the verification list, ahead of spot gold.

On size, "it's about how to sleep" misses two things. The 0.3% loss figure assumes the loss is isolated. Beta is 1.52 and the whole miner group is giving back its August rally, so if you hold other gold, commodity or high-beta names, the gap that hits KGC probably hits them too. We don't know the caller's book, so the guidance has to be conditional. Also, if the downside is a few tenths and the upside is a few tenths, the starter's expected value is small too. The real risk is process. Every version of this plan has attached an add to the starter, and the add is where books get hurt.

Neutral, that applies to your replacement add. A close above 23.63 is only about 1.4 ATR from here. An oversold RSI of 29 will bounce that far on almost any day. The next hurdles are the 24.88 mid-band and the 25.27 daily SuperTrend, only 5 to 7% above a roughly 23.7 entry. A stop under 21.90 is about 8% below it. That's worse than 1:1 to the nearest resistance, and it would fire on a dead-cat bounce. If you want an add, tie it to something that resolves the uncertainty, which means the print, or at least a close above 24.88.

And waiting doesn't forfeit the trade. If a clean print gaps the stock to about 24.50, the 50 SMA and UBS's $28 target are still 12 to 14% above, with a stop in the low 23s. That's a respectable reward-to-risk with the biggest unknown removed. Both of you are comparing 22 against 25.27, but the real comparison is 22 now against about 24 or 25 after the print.

So my recommendation stays the same, trimmed to what the debate has settled. If you're flat, stay flat through the 28 October print and the 29 and 30 October closes. Judge the print against consensus and the guide, and treat the middle zone as hold and add nothing. If you insist on exposure before then, it should be no more than Neutral's 0.15x, with no add, only after you've confirmed the bar is final, spot gold, and why it gapped today. If you already hold KGC, don't add, and treat 19.6 as a gap-risk level, not a guarantee. A drop worse than 11.6% is possible, and it would likely hit the rest of your book at the same time. Conservative Analyst: Let me start with what I'm taking from you both, because it's a lot. Aggressive, you've dropped the $20 add, the convexity thesis, the 25.27 strawman and the idea that 19.6 protects anyone. Neutral, you've shrunk the starter, dropped the reclaim add, and the peer test is a good idea. You're also right that my 24.50 entry with a stop in the low 23s is the same dead-cat distance I criticized in your add, and that I was comparing a conditional trade to an unconditional one. I'll fix that below.

The agreement hides a flaw in the sizing rule you both converged on. You said each add should be sized so a stop-out costs 0.3 to 0.5% of the book. That is sizing off the distance to the stop, and a tight stop makes the position bigger. If I buy at 24.50 with a stop 5% below, a 0.4% budget gives me an 8% position, which is 0.8x on a single add. This stock gapped 11.6% on 24 September and 5.1% today. On that 8% position, an 11.6% gap costs about 0.9%, more than twice the budget you thought you had. Risk-based sizing assumes the stop executes, and this tape has twice shown it doesn't. So size on an assumed gap loss of about 12%, not on the stop. A 0.3 to 0.5% budget for the whole gold-beta sleeve then caps KGC at roughly 2.5 to 4% of the book, which is 0.25x to 0.4x in total. That is a ceiling, not a per-add allowance. Reclaiming the 50 SMA at 27.59 doesn't change it, because price would still sit below the 200 SMA at 29.20 and the weekly SuperTrend at 31.25.

Neutral, your 8x to 11x range is circular. The 8x floor is today's multiple. The stock traded near 12x in August and has lost a third of its multiple in seven weeks, and the range assumes that stops exactly where we're looking. At 7x on the bear EPS you're at about 17, and nothing in the data says 8x is a floor. Averaging the endpoints gives a midpoint, not an expectancy, so I wouldn't call it a 10% expected return.

Aggressive, you said the guidance hit is already in the price. The cut day closed at 24.42 and the stock is now 9% below that, with no new company news in the headlines. Either the cut wasn't fully priced or the macro is doing the repricing, and macro is unresolved: 86% odds of another hike, and a 54% chance gold touches $4,000 with 28% for $3,900. Measuring from 27.62 flatters the discount, because that price sat inside an August rally that has been fully erased.

On the print, I can't prove the skew is negative, and I'll drop that claim. But your three reasons don't establish a positive skew either. If management reset the outlook six days before quarter-end, knowing Q3, then Q3 at La Coipa and Round Mountain was probably tracking weak. A beatable bar affects the guide, not the reported quarter, and the cost and capex lines are where Q2 disappointed. Also, if clearing the bar is easy, clearing it is the consensus outcome, and consensus outcomes don't produce 10% gaps. You can't say a second cut is unlikely and also that avoiding one will pop the stock. On the 50% return target, Q2 buybacks were $230M, after $250M in Q1 and $265M in Q4. Buyback pace has fallen three quarters running, so I wouldn't count $450M of extra yield until the 28^th shows it. The timing of the guidance cut is also unconfirmed, so you're stacking inference on inference.

On "being wrong costs a few tenths of a percent": you described the print as +10% or -10% on a small line, which is symmetric. Waiting costs you the first leg of a good outcome, but it also saves you the bad one. You've only counted the branch where waiting loses. With no edge on the print, the starter's case rests on the six-to-twelve-month view, which doesn't depend on getting in this week. A starter this small is worth plus or minus 0.15% of the book either way, and at that size what protects the book is process.

The peer test has a flaw too. If KGC fell in line with its peers, the starter stands, but that is exactly when your correlation risk is highest. The test screens out a company-specific story and passes the sector-wide, rates-driven selloff, which is the unresolved risk. I'd add Q3 average gold against Q2 to the gate list, since that tells you more about the print than January's price. Nobody here knows it, and the "August rally suggests it wasn't lower" argument is a stock move, not a gold series. Limit orders at 21.90 to 22.40 also have adverse selection. In a downtrend, the lower fills happen mostly when the low breaks, which is the continuation scenario.

Here is my position. If you're flat, don't initiate before the 28 October print and the 29 and 30 October closes, because every gate on the list is unverified and none can be checked from here. If the desk insists on exposure before then, the version I'd sign off on is at most 0.15x, only with no other gold beta in the book, with no stretch to 0.25x, no add before the print, and only after the bar, peers, spot gold, Q3 average gold, guidance timing and consensus all check out. If you already hold KGC, don't add, and treat 19.6 as the level where you review the thesis, with a 12% gap assumed across the whole sleeve. After the print, size on the gap loss, not the stop distance, and let information, not a bounce above 23.63, decide each add. Conservative Analyst: We've converged enough that I'll be brief about what's settled. Nobody is defending the $20 add, the walk to 1.0x on a 25.27 flip, the 0.5x pre-print cap, or the idea that 19.6 is a stop that will fill. We're all at 0.15x, no add before the print, sized on gap loss rather than stop distance. I'm not going to relitigate that. What's left is whether to put the first slice on before the 28^th, and what to call the recommendation. On both I still land on waiting.

Aggressive, start with your own grid. It averages about 23.5, roughly 6% above the close, with a 24% loss in the 7x case. You picked six equally weighted points, so as you said, it isn't an expectancy. And 6% over six to twelve months on a stock with a beta of 1.52 isn't an edge. It's about what market risk alone should pay, before the production reset and the cost questions. I don't have a risk-free rate because the FRED pull failed, but every headline says yields are at multi-year highs and still rising, so the hurdle isn't low. Your own bad case is also twice the 12% gap we all sized on. That gap is the worst we've watched so far, not a worst case. For 0.15x the difference is small. For anyone who already holds the name or other gold, I'd stress the sleeve at 20 to 25%.

On the cost of waiting, you said it costs about 10% of price because the post-print entry is near 24.50. That was my number for a clean print, which is the good branch. You've also told me the likeliest outcome is an in-line print and a small move. In that branch waiting costs nothing, because you're buying near 22 or 23 with the event behind you. In the bad branch waiting saves you the gap. You only pay up in the good branch. Weighted on your own distribution, waiting is close to free. You can't use the center of the distribution to shrink the starter's risk and then use the good tail to inflate the cost of waiting.

Your "in-line is likeliest" point also needs consensus to be current, and I'm not sure it is. Forward EPS of $2.78 sits only 1 to 2% below the $2.80 to $2.84 run rate. Either the guidance cut was small in earnings terms, and then a 19% drawdown is a large overreaction, or the vendor figure hasn't caught up. If it's stale, the real multiple is higher than 8x, and an in-line print against an old number is a miss against the new one. That's why the date of the consensus figure belongs on the gate list alongside the number itself.

On the balance sheet, I agree nothing breaks. But the book's risk is the mark, not solvency. Cash rose from $1.74B at year-end to $2.19B in Q1 and $2.66B in Q2, and the stock still lost 41% from January and a third of its multiple in seven weeks. A strong balance sheet hasn't been what sets the price.

Neutral, I agree with your mechanics: one clip, no ladder, no verification, no order. But your clip range of 22.00 to 22.40 contains today's close, so the order is effectively a market buy on a bar that may be provisional, the morning after a gap nobody has explained. That makes the gate list the whole decision. Seven checks, none verifiable from here, a 1.5% position, no add, and a thesis review in place of a stop. That is a Hold with an option attached, and I think it should be labeled that way. The trader's original plan carried a Buy label along with a ladder to 1.0x, and the headline travels further than the gates do. Labeling this a Buy invites someone to execute the headline without the conditions.

One last point. "Review at 19.6 on a close" is a discussion, not an action, and losing positions usually get held through discussions. Pre-commit the action. If it closes below 19.6, cut at least half. And on the FOMC date, two of you recalling the same calendar from memory is one recollection, not two sources. Confirm it, because the 29^th and 30^th closes only mean something if you know what else landed on the 28^th.

So here is my position. If you're flat, wait through the 28 October print and the 29^th and 30^th closes, and judge the print against a dated consensus and the guide, with the middle zone meaning hold and add nothing. If the desk wants exposure before then, it should be at most 0.15x, in one clip, with no other gold beta in the book. It should go in only after the bar, peers, spot gold, Q3 average gold against Q2, the guidance timing and the consensus vintage are confirmed, and with a pre-committed cut at a close below 19.6. If you already hold KGC, don't add, and stress the whole gold sleeve at 20 to 25%. Conservative Analyst: We're now agreeing on almost every mechanical point: one clip at 0.15x, no add before the print, sizing off the gap instead of the stop, and post-print judgment against a dated consensus. I also accept Neutral's cut to four gates. And Neutral is right that I leaned on "in-line is likeliest," a premise I'd attacked when Aggressive used it. I don't need it. If the print is symmetric, waiting costs nothing in expectation, whatever the odds of an in-line result. Waiting gives up the first leg of a good outcome and avoids the bad one.

Five disagreements remain.

First, the earnings-reaction check is one-sided. Aggressive says that if the last four reactions are 3 to 5%, waiting buys nothing. But a small number only makes the starter's print risk small and its print upside equally small. It can show the starter is harmless, never that it's worth doing. Only a large number moves the decision, and it moves it toward waiting. So it can't count as a reason to buy. Fix the middle band now, before anyone looks. I'd say 5 to 8% means wait, so the number isn't interpreted after the fact.

Second, the label. Aggressive's own default for a flat book that hasn't run the checks is wait. Nobody here can run those checks. Bar finality, peer moves, the print time, the FOMC date and the caller's other gold exposure are all outside our data. So what we're actually delivering is wait, with an option attached, and a Buy headline describes the rarer branch. The misreading risk is also asymmetric, which is the logic we used on sizing. If the label is too cautious, someone misses a 1.5% position we all put at plus or minus 0.15%. If it's too aggressive, someone executes the headline along with the original ladder, where we found roughly 2.2% at risk. I'd pick the label whose failure costs a tenth of a percent. I don't care about the word as much as the first sentence: do nothing until the print unless these four things are confirmed.

Third, the exit rule. A pre-committed cut on a close below 19.6 is the right instinct, but that level sits almost exactly where our budget already assumes the worst gap, about 12% below the close. A close-based rule sells the next session, after the gap, so it limits the second leg, not the first. The realized loss on a 0.15x line is therefore a bit above the 0.18% we keep quoting, and on this tape the next-day move isn't trivial. It's small in dollars, but we keep calling this "defined risk," and it's defined only up to the gap.

Fourth, the balance sheet. Aggressive, net cash of $1.59 a share is correct. But the stock has lost about a third of its value since August, roughly $13 billion of market cap against $1.9 billion of net cash. A $0.9 billion cash build can't be the evidence that the market is wrong, because the market is repricing the other 93%, the claim on future cash flows. Some of that cash is also spoken for. The tax payable is $587 million, of which about $300 million is the catch-up Neutral identified, and there are about $976 million of long-term provisions. Netting only the catch-up puts the cushion nearer 6% than 7%. The cash is also piling up instead of going back to holders. Buybacks have fallen three quarters running while free cash flow stayed above $700 million.

Fifth, an input nobody has put on the list: what gold price the $2.78 forward EPS assumes. All our sensitivity math is relative to Q2 realized prices, and the 8x multiple depends on a gold deck we haven't seen. If consensus sits above where spot is now, and we only have one unverified post saying roughly $4,107, then the multiple at spot is higher than 8x and estimates have to come down. Aggressive, you say stale consensus only hurts if true EPS lands below $2.42. That's right for where the stock eventually trades. It isn't right for the days around the print, when the estimate reset itself is the news. The stock has also fallen about 9% since the guidance-cut close of 24.42 with no new company headline, which suggests macro is doing the repricing, and macro hasn't resolved.

My position, as an adjustment to the trader's plan:

Drop from the plan: the $20 add, the 0.5x pre-print cap, and the walk to 1.0x on a 25.27 daily flip.
Flat, or checks not run: wait through the 28 October print and the 29 and 30 October closes, then judge against a dated consensus and the guide. The middle zone means hold and add nothing.
Flat, checks passed: at most 0.15x in one clip with no ladder. The checks are a final bar, KGC within about three points of NEM, AEM and GDX, no other meaningful gold beta, a confirmed print and FOMC calendar, and modest earnings-day reactions. Cut all of it on a close below 19.6.
Already holding KGC or other gold: don't add. Stress the whole sleeve at 20 to 25%, and treat that as a judgment, not data.

None of us disputes that this is a price worth owning over six to twelve months. The dispute is only whether the first 1.5% should go on two weeks before an event none of us can read, and the default should lean toward not doing it.

Neutral Analyst¶

Neutral Analyst: I think each of you is right about the thing you're afraid of, and each is too comfortable with your own fix.

Aggressive analyst first. You keep framing the alternative as waiting for the daily SuperTrend to flip at 25.27 and paying 14% more. That isn't your own plan, which buys the last tranche on a close above 25.27 and will pay up to 25 after a clean print. The real choice is a starter now versus a starter after something cheaper than a full flip, like a close back above the 23.44 gap origin and the 23.63 EMA, or the print itself.

Your 2:1 only works if the stock gets all the way to the 50 SMA at 27.59. In the bear case you built the valuation around, 10x on $2.42 gets you about $24.20. That's 9.5% up against an 11.3% stop. You can't use the bear EPS as your floor and consensus as your payoff.

The convexity argument has a similar problem. Hot CPI, a global bond selloff and oil near $103 are all here today, and gold still fell more than 1%. Trump has also just shrunk the Iran tail. These might help eventually, but you can't time them, and I wouldn't pay for them with a position going into a print.

The $20 add is the weakest piece. Nothing in the data marks $20 as a level. By my rough math, a 5% gold dip to $3,900, which the thin markets put at 28%, is about a 9-10% hit to operating income at Q2's leverage. At a constant 8x that is a stock near $20, so the add sits where a fairly plausible outcome lands, with a stop 40 cents away. The one StockTwits bull is "adding down at scale" too, which is the same behavior, not a signal.

Also, the 11% FCF yield isn't what a holder collects. The cash returned is about 4.1%, so two weeks of sitting out costs roughly 0.16%.

Conservative analyst, your trend-filter argument proves too much. You say stay out because all three tiers are down and ADX is 36.8. But you'd start buying on 29-30 October after a clean print, with all three tiers still down and the stock probably at 24 or 25. That is an event filter, not a trend filter. It's a fine rule, but then the trend can't be what forbids a starter.

"Sequencing is the one risk we can fully control" is also too strong. Waiting swaps the risk of a bad print for the risk of a good one that you then chase, and given the last two gaps the print is plausibly a move of 8-12% either way.

Most of your unverified inputs also don't need two weeks to resolve. Spot gold, whether today's bar is final, the FOMC date and the size of the guidance cut can all be checked in minutes. The "fell 12%" headline matches the 11.6% gap on 24 September, which suggests the cut is already in the price, though that's my inference and worth confirming.

On earnings quality, you asked what filled the gap between pre-tax income falling $139M and flat operating cash flow. The answer is mostly cash taxes, which fell from about $449M in Q1 to $327M in Q2, a drop of $122M. Over the last four quarters the tax provision was about $1.21B against roughly $0.9B of cash taxes. That roughly $300M gap matches the rise in the payable almost exactly, and it built up in the second half of 2025, when cash taxes were tiny. In the first half of 2026, cash taxes roughly equalled the provision. So Q2's $735M of FCF is already fully taxed, and the $587M payable is a catch-up risk of about 49 cents a share, around 2% of the price. That helps the aggressive more than you'd like, though the tax lines have a vendor quirk, so I'd hold it loosely.

Your own stress test also needs a 10% fall in realized prices. That is roughly the $3,700 touch market, which has 7% odds. And one more Q2-sized step down in pre-tax income gets you to about $2.50, so the $2.42 bear case is already harsher than a repeat.

Where I agree with you is the Q1 tax rate of 35%, which was the outlier. Q2's 28% is normal, so Q2 EPS isn't flattered, but there is no tax cushion left if pre-tax keeps falling.

One gap I'd like both of you to close is what gold has done since January. The stock is down 41%. If gold is down 10%, KGC is behaving like a levered miner, and cheap mostly reflects that. If gold is flat, the stock has de-rated on company-specific problems. Those are different trades, and nobody has checked.

So here is the adjustment I'd make. Keep the direction, but shrink and condition it.

Verify first: confirm the bar is final, spot gold and the guidance date before any order goes in.
Pre-print size: a starter of about 0.15x, with total pre-print exposure capped at 0.25x instead of 0.5x. On the trader's own math, a repeat gap then costs under 0.2% of the portfolio.
The $20 add: drop it. Replace it with a roughly 0.1x add on a daily close above 23.63 that holds 23.44, with its own stop under the 21.90 low.
Post-print rules: measure the print against consensus and the guide, not against Q2's numbers. Define the middle zone as hold what you have, add nothing, and let the 29-30 October closes decide.
If you already hold KGC: don't add before the print.
If you're flat: the small starter is reasonable. Waiting is also defensible, but it isn't free.

So my answer is a smaller, conditional Buy. It is neither a Hold nor the plan as written. Neutral Analyst: You've both moved enough that I'd stop arguing the parts we now agree on and look at the parts nobody has tested.

On the trader's own arithmetic, where 0.25x is about 2.5% of the book, a repeat gap costs somewhere between 0.17% and 0.3%. Aggressive calls that a question of how to sleep. Conservative says the expected gain is just as small. Both are right, which tells me the starter isn't where the decision lives.

Conservative, you've earned three concessions. First, the reclaim add is gone. A close above 23.63 is about 1.4 ATR away, an RSI of 29 will do that on a quiet day, and a stop under 21.90 is wider than the room up to 24.88 and 25:27. I also accept that every version of this plan hangs an add on the starter, and that's where books get hurt, so there's no pre-print add at all. Second, the correlation point. With a beta of 1.52 and the sector handing back the whole August rally, 0.15x of KGC on top of other miners isn't 0.15x of risk. Count the gold beta across the book, not the line item. Third, "why did it gap today" belongs on the list, but I'd make it a test. Compare KGC's move with a peer or a miners ETF. Miners often move several times what gold does on a risk-off day, so a 1% gold drop alongside a 5% miner drop isn't strange in itself. If peers fell about as much, it's sector beta and the starter stands. If KGC lagged the group by several points, something specific is going on and I'd wait until it's explained.

Where I push back on you is the skew. You inferred a negative skew on the print from the cost and capex lines, and I don't think the sign is established. Production guidance was reset three weeks ago, and a second cut so soon after a reset is less likely than the first. That's my inference, not data. Q3 revenue is mostly observable, so consensus already reflects where gold averaged, and nobody has checked whether that average was above or below Q2. The August rally suggests it may not have been lower. There's also an upside lever. The return target was raised to 50% of free cash flow, while Q2 returned about $278M against $735M of FCF, roughly 38%. If the new target is real, that's around $450M a year more, about 1.7 points of yield. I can't say it shows up on the 28^th, but it makes the print less one-sided than "a bad gap needs only one of two things."

I'd also hold your wait-for-the-print example to the standard you set for my add. A clean print gaps to 24.50 and you put the stop in the low 23s. That's about 1.3 below entry, roughly 1.4 ATR on today's volatility, the same distance you said fires on a dead-cat bounce. You're also comparing a conditional trade, the one you take after good news, to an unconditional starter. If good and bad prints are about equally likely, the starter has little edge on the print itself. Its edge is on the six-to-twelve-month valuation. That argues for keeping it small, not for skipping it.

Aggressive, you keep reaching for the August multiple. 33.48 came after a 42% run in three weeks from 23.57, so it's the top of the range, not a base case. A fair spread is 8x to 11x on EPS between $2.42 and $2.78, which is roughly 19 to 31, centered in the mid-20s. That's a positive expectancy of around 10% with a wide range, which supports owning a modest amount. It doesn't support saying the trade needs no recovery. I'd also drop the MFI and ADX points. MFI is above its lows only because price fell further, MACD is drifting down again, and the MFI scale is unverified.

The bigger problem is that we've spent three rounds on a 2.5% position and none on the part of the plan that carries the risk. After the print, the plan adds 0.35 to 0.4x, then takes the rest to 1.0x on a close above 25.27, with the weekly stop at 31.25 and the monthly at 37.01 still pointing down. If the stop stays at 19.6, a position entered near 25.27 has about 22% to the stop. If 1.0x is about 10% of the book, that is roughly 2.2% at risk, about seven times the repeat-gap cost we've been debating. That isn't defined risk. Either the stop ratchets up with each add, or size doesn't reach 1.0x while the higher-timeframe trend is still down.

So here is where I land, and it's still a smaller, conditional Buy.

First, verify before any order goes in. Confirm the bar is final, check how peers moved today, check spot gold and where it stood in January, and confirm the guidance date and what consensus expects for Q3, including buyback pace. If KGC badly lagged peers or gold is well below the assumed level, wait.

If those pass and you're flat, take a starter of about 0.15x on limits in the 21.90 to 22.40 area, with no add before the print. Treat 19.6 as a disaster level rather than protection. If you already hold 0.15x or more of KGC, or hold a lot of other gold beta, don't add.

After the print, judge it against consensus and the guide rather than Q2's numbers. If it's clean, add up to about 0.25x more and move the stop under the post-print low, so the total sits near 0.4 to 0.5x. In the middle zone, hold and add nothing. If it breaks, with a deeper cut or margins well under consensus, exit.

A close above 25.27 earns a modest add, not the run to 1.0x. Full size waits for something from the higher timeframes, such as a reclaim of the 50 SMA near 27.59. At every step the risk per add should stay near 0.3 to 0.5% of the book, not grow with the position.

If you're flat and the checks fail, waiting is fine. If they pass, the starter costs about 0.17% in a repeat gap and keeps you in the trade if the print is good. Most of the work in this plan is done by the conditions, not by the starter. Neutral Analyst: I think we've converged more than the tone suggests, so I'll start with what I'm taking and then say where each of you is still shading things.

Conservative, your correction on sizing is the most useful thing said this round. The trader's original starter was already sized off the gap: 0.3% divided by 11.6% is about 2.6% of the book. The flaw is in the adds and in the "0.3 to 0.5% per add" rule that Aggressive and I borrowed from stop-based sizing. A tight stop inflates the position, and this tape has gapped through two levels in three weeks. So every tranche gets sized on an assumed gap loss of about 12%, and the cap is the sleeve's loss budget divided by 0.12. A 0.5% budget gives roughly 4% of the book. The "1.0x equals 10% of the book" figure is our illustration, not something the trader gave, so the caller needs to rescale it. The walk to 1.0x on a 25.27 daily flip is gone. A bigger position can come later, but only as a deliberate decision to raise the budget, not as a ladder that drifts there.

Aggressive, three things. First, "information isn't free, you pay for it in price" counts only the branch where waiting loses. Conservative is right that a bad print saves the person who waited. Second, you said stretching from 0.15x to 0.25x costs about a tenth of a percent. It also gains about a tenth. If the stakes are that small, there's no reason to stretch, so I'd stay at 0.15x. Third, the gold sensitivity math, mine included, is all relative to Q2's realized price, and none of us has it. "Mid-$3,000s" means about 17.7% below Q2's average, which is an unknown level. It tells you the stress case is a tail, not where the floor is. I'm also retracting the 50%-of-FCF return target as an upside lever. Buybacks have gone from $265M to $250M to $230M over three quarters, so it's an option that only counts if the 28^th shows it.

Conservative, I push back on a few things. You're right that waiting is cheap. A clean print gets you in near 24.50, which is still about 8.8x forward. But that cuts against the starter's importance as well. The print is roughly symmetric, so the starter's edge is the six-to-twelve-month valuation, and timing within two weeks barely matters to that. That's the argument for keeping it small and optional, not for banning it. Your entry after the print also isn't structurally safer under your own sizing rule. It removes the event gap, but the macro gap is still there at the same 12%.

On "every gate is unverified and none can be checked from here," that's true of our tools but not of the caller. So the rule I'd use is no verification, no order. If the desk can't confirm the bar is final, how KGC moved against peers, spot gold, the Q3 average against Q2, the timing of the guidance cut and consensus, the default is to wait.

You're also right about the peer test. If KGC fell in line with peers, the idiosyncratic story is cleared but the correlation risk is at its highest. The test screens out one problem. Sleeve-level accounting handles the other, which is why "no other gold beta in the book" has to be a condition and not a preference. Your point on limit orders is fair too. Bids resting at 21.90 fill mostly when the low breaks, which is the continuation case. So the starter should go in as one clip in the 22.00 to 22.40 area. There should be no ladder below 21.90, and if the stock trades through that low unfilled, stand aside rather than chase it down.

There's one more item for the check list that none of us has raised. My recollection is that the October FOMC meeting falls in the last week of the month, right on top of the print. That's from memory, not our data, so confirm it. If it's true, the window carries a rates decision and earnings together. That's a further reason for 0.15x and no add before the 29^th and 30^th.

My bottom line is still a smaller, conditional Buy.

If you're flat, hold no other gold beta, and every check passes, take about 0.15x in one clip near the current price, with no add before the print. Treat 19.6 as the level where the thesis is wrong, reviewed on a close, not as a stop that will execute. Count a 12% gap loss against the whole gold sleeve. If you already hold KGC or meaningful other gold exposure, don't add. If any check fails or can't be confirmed, wait, and accept that this costs roughly 0.15% in carry and a higher entry if the print is good.

After the print, judge it against consensus and the guide, not against Q2. If it's clean, add one tranche sized on the 12% gap, with the review level under the post-print low and the total inside the sleeve budget, which is about 0.4x on our illustrative scale. In the middle zone, hold and add nothing. If it breaks, with a deeper cut or margins well under consensus, exit.

Aggressive is right that this is a price worth owning and that sequencing has a cost. Conservative is right that the real control is size and process, not stops. The trader's plan had the first and not enough of the second. Neutral Analyst: Before the remaining disagreement, I want to size what it's worth. At 0.15x on our illustrative scale, the position is about 1.5% of the book. A 10% move on the print is 0.15% of the book either way, and two weeks of expected drift on that line is a rounding error. We've spent most of this debate on a decision worth a tenth or two of a percent. That makes the process the real question, and that's Conservative's point, which is mostly right.

Aggressive, on your last round: the six-point grid averaging 23.5 is a fine illustration, but you picked the points, and a different set gives you 10% or zero. About 6% over a year on a 1.52 beta is roughly what the market pays you for the risk with no mispricing, so I'd stop calling it an edge. The balance sheet argument has the same problem. I agree nothing breaks with $2.66B of cash and 0.08x debt to equity, but that supports holding through a drawdown, not taking print variance two weeks early. You also can't say that being right and absent costs about the same as being wrong, and then say waiting costs you 10% of the price. Waiting only costs you in the good-print branch, and there you're still buying at about 8.8x forward.

Conservative, you're closer on the default, but you overreach in three places. Seven gates is too many. Some decide whether to buy a starter, and others only matter for judging the print, like Q3 average gold against Q2 and the date on the consensus number. Mixing them makes the list look impossible, and a list that looks impossible gets rubber-stamped or ignored. Second, "waiting is close to free" leans on the in-line print being most likely, which is the premise you attacked when Aggressive used it. Nobody has measured that distribution. I also need to own a piece of this. I said the print is plausibly an 8 to 12% move either way, based on the last two gaps, but neither gap was an earnings day. One was a guidance cut and the other is still unexplained. The size of a typical KGC earnings reaction is unmeasured, and pulling the last four takes a minute. If they're 3 or 4%, the starter's print risk is negligible, and so is the cost of waiting. If they're 8% or more, that argues for waiting. Third, the 20 to 25% sleeve stress is a judgment, not a measurement. The worst gap in our data is 11.6%. I'm happy to apply the bigger number to someone who already holds gold, since caution is cheap there, but it shouldn't be presented as data.

I'm taking several things from you. The conditions have to sit inside the action text, because you're right that a Buy headline travels further than its gates. A close below 19.6 should trigger a pre-committed cut, not a review. At 0.15x I'd cut all of it, since keeping half is a decision worth almost nothing. The FOMC date is one recollection, not two, so confirm it. The release time also matters, because if results come after the close on the 28^th, the first reaction bar is the 29^th. And a 22.00 to 22.40 limit contains today's close, so nobody should place it tonight on a bar that may be provisional.

Here's where I land. The Buy survives as a six-to-twelve-month direction. What changes is that the pre-print piece becomes optional rather than the plan. For a flat book, the starter is up to 0.15x in one clip on a limit in the low 22s, with no ladder below 21.90 and no chasing if it runs. There are four checks:

The bar is confirmed final, and the entry session doesn't close below 21.90.
KGC hasn't lagged NEM, AEM or GDX by more than about three points. This only screens out a company-specific story, which is why the next check is separate.
The book has no other meaningful gold beta, with a 12% gap loss fitting the sleeve budget.
The calendar is confirmed: print date and time, FOMC date, and the last four earnings-day reactions. If those reactions are large, I'd lean toward waiting.

If any check fails or can't be run, the action is to do nothing until the print.

The post-print rules are identical whether or not you took the starter. Judge the result against a dated consensus and the guide, not against Q2. If it's clean, add one tranche sized on the 12% gap, inside the sleeve budget, with the review level under the post-print low. If you can't find consensus, don't add. In the middle zone, hold and add nothing. If it breaks, exit. If you skipped the starter, that first tranche is just the starter at the same size.

If you already hold KGC or other gold, don't add before the print, and stress the whole sleeve at 20 to 25%.

Aggressive is right that this is a price worth owning. Conservative is right that the first slice is worth almost nothing unless you have a view on the print, and nobody has shown one. So for a flat book that hasn't run the checks, the answer is wait. If the checks pass, it's a Buy of 0.15x and no more, with the 0.25x, 0.5x and 1.0x ladder dropped from the plan. Neutral Analyst: Most of the mechanics are settled, so I'll take the five open points and say where each of you is still stretching.

The earnings-reaction check first. Conservative is right that it only works one way. A small past reaction makes the starter harmless, not worthwhile. So all the checks should be vetoes, not reasons to buy. The only reason to buy is the six-to-twelve-month valuation, and the checks decide whether this particular week is acceptable for acting on it. I'll fix the band now, as asked: if the last four earnings-day moves were all under about 5%, the check passes, and at 5% or more you wait. Four data points is a thin sample, so it's a rough screen. Aggressive, you said you'd accept whatever it shows, and the best it can show is "not a reason to wait."

On the label, I'll concede part of this to Conservative. His asymmetry argument is the best one on the table. A Buy headline read without its conditions risks someone executing the original ladder, and a cautious headline read the same way costs a tenth of a percent. So the first sentence should be the condition: do nothing until the print unless four things are confirmed, and then up to 0.15x in one clip. I'd still call the direction a Buy and not a Hold. Hold tells the reader nothing about the post-print tranche, and it reads as "don't own it," which none of us believes. If the sentence can't survive being read alone, the label won't save it.

Conservative, you also keep saying the gates can't be checked from here. That's true of our tools, but the caller can check the bar, the peer moves and the calendar in minutes. So "no check, no order" is the right default, and "we can't verify it" isn't a reason to wait in itself.

The exit rule is a fair hit. A close-based cut at 19.6 sells after the gap, so the realized loss on a 0.15x line is gap plus slippage, nearer 0.2 to 0.3% than the 0.18% we keep quoting. It's still small, but "defined risk" means defined up to the gap. So I'll pre-commit to cutting all of it on a close below 19.6, and I'll budget the loss at the higher number.

On the balance sheet, you're both overusing it in opposite directions. Aggressive, the cash build isn't evidence of mispricing. The market is repricing the claim on future cash flows, and cash is the small part of that. Conservative, "spoken for" is also overdone. The $976M of provisions is long-dated reclamation, not a bill due this year, so netting it fully is as wrong as ignoring it. Depending on what you net, my rough arithmetic puts the cushion anywhere from about 2% to 7% of market cap. That range is the point. Net cash tells you the thesis won't break on solvency, and it doesn't tell you where the stock should trade. It supports holding through a drawdown, not buying early.

The gold deck behind the $2.78 is a good addition, and it's the strongest reason to doubt the 8x. But it isn't a starter gate. It doesn't change whether a 1.5% line is acceptable this week, and the print will reset estimates anyway. It belongs in the post-print judgment. When you look for a dated consensus, also ask what gold price it assumes and compare that with spot. If consensus sits well above spot, the true multiple is higher than 8x and any add should shrink or wait.

Here's what I'd say to each of you as we close. Aggressive, you've now agreed that the pre-print edge is roughly nil, that waiting costs something only in the good-print branch, and that the 6% grid average is just market beta. What's left of "Buy now" is the view that it's a fair price to own over the long run. That's true, but it's also true on October 30. Conservative, you've agreed the starter is worth plus or minus 0.15% of the book. A rule that costs that little can't be called reckless either, and if the checks pass and the sleeve is empty, forbidding it is as much a judgment call as allowing it. Neither default is demonstrated. We're choosing between two cheap mistakes, so choose the one that's easier to execute correctly.

My recommendation is a conditional Buy with a default of waiting. If you're flat and haven't run the checks, do nothing until the print. If you have, and the bar is final, KGC hasn't lagged NEM, AEM or GDX by more than about three points, no other meaningful gold beta sits in the book, and the print date and time, the FOMC date and the earnings-day reactions are confirmed and modest, take up to 0.15x in one clip, with no add before the print. Size every tranche by dividing the sleeve's loss budget by 0.12, not by the stop distance. On our illustrative scale a 0.5% budget caps the whole name near 0.4x, and you should rescale that to your own book. Cut everything on a close below 19.6.

After the print, judge it against a dated consensus and the guide, with the gold assumption checked, and let a day or two of closes settle if the FOMC lands close to the release. If it's clean, add one tranche inside the cap. In the middle zone, hold and add nothing. If it breaks, exit. If you already hold KGC or other gold, don't add before the print, and stress the whole sleeve harder than 12%, knowing that number is a judgment and not data.

The original plan's $20 add, the 0.5x pre-print cap and the walk to 1.0x on a daily flip should all go. The direction survives and the ladder doesn't.

V. Portfolio Manager Decision¶

Portfolio Manager¶

Rating: Overweight

Executive Summary: Overweight KGC over 6-12 months, with a default of no action before the 28 Oct Q3 print. If you are flat, buy only if four checks pass: today's bar is final, KGC fell within about 3 points of NEM/AEM/GDX, your book holds no other meaningful gold beta, and the print/FOMC dates are confirmed with the last four earnings-day moves all under about 5%. If they pass, take at most 0.15x a standard allocation in one limit clip in the low 22s, with no orders below 21.90, no add before the print, and a full exit on any close below 19.60. Size every tranche on an assumed 12% gap loss (your gold-sleeve loss budget divided by 0.12), not on stop distance, which caps the whole name near 0.4x on an illustrative scale where 1.0x is 10% of the book; existing KGC or gold holders should not add before the print. After the print, judged on the 29-30 Oct closes against a dated consensus and the guide: clean means add one gap-sized tranche within the cap, middle zone means hold and add nothing, break means exit; price target $24.70.

Investment Thesis: Decision and why. All three risk analysts, the Research Manager and the trader agree that KGC is worth owning over 6-12 months at about $22. The only real dispute is whether to put on a first slice before the 28 Oct print. That is a favorable outlook with gradual, gated accumulation, which is Overweight. It is not Buy, because the debate stripped out most of the claimed edge. The Aggressive analyst conceded that his six-point valuation grid averages only about 23.5, roughly 6% upside, which is about what a 1.52-beta stock should earn anyway. He also withdrew the convexity thesis, the $20 add and the 'waiting costs 10%' argument. On top of that, every trend tool is bearish: all three SuperTrend tiers point down, ADX is 36.8, price sits below the 10 EMA (23.63), 50 SMA (27.59) and 200 SMA (29.20), and today's 22.24 is the lowest close in 252 bars. Momentum offers no reversal signal either: RSI is 29 with no bullish divergence, the Z-score is only -1.3, and MACD has not crossed up. It is not Hold, because the fundamental floor is real and undisputed. The stock trades at 8.0x forward EPS of $2.78 and 8.5x trailing, with about 4.5x EV/EBITDA, an ~11% FCF yield and 37% ROE. Operating cash flow has held near $1.14B a quarter for three quarters, after heavy cash taxes, and net cash is about $1.9B after the $502M debt paydown. Even the bear's $2.42 EPS case puts the stock at only 9.2x.

Why the plan is cut back. The Conservative analyst won the process argument, and the trader's ladder is dropped. Sizing off the stop fails on a stock that gapped -11.6% (24 Sep) and -5.1% (today) in three weeks, so every tranche is sized on a ~12% gap loss. Gap risk is also counted across the whole gold sleeve, because a sector-wide, rate-driven selloff would hit all gold names together. The $20 add, the 0.5x pre-print cap and the walk to 1.0x on a 25.27 daily flip are removed. The Neutral analyst showed that path left about 2.2% of the book exposed against a 19.6 stop. The Neutral analyst also showed that the starter is worth only about ±0.15% of the book. So the pre-print slice is optional, gated by vetoes, and sized at 0.15x, about 1.5% of the book on the illustrative scale. A repeat gap would cost roughly 0.2-0.3% after slippage, because a close-based exit sells after the gap.

Post-print rules. Judge the print against a dated consensus and management guidance, and check what gold price that consensus assumes. If consensus sits well above spot, the true multiple is above 8x and any add should shrink or wait. If no dated consensus is available, do not add, and use the plan's Q2-based thresholds only as the exit test: break if gross margin is below 53%, FCF below $575M, unit costs rise despite lower volume, or 2027 is cut further. Clean means gross margin of 57% or more, FCF of $735M or more, flat or lower unit costs and no further cut. A daily close above 25.27 earns at most a modest add inside the cap. Going beyond the cap requires a deliberate decision to raise the loss budget, plus a reclaim of the 50 SMA near 27.59, quarterly buybacks of $300M or more, and gold holding above ~$4,000.

What would change the call. Downgrade to Underweight or exit on any of the following: a close below 19.60; a broken print; gold holding below ~$3,900; buybacks falling again after the print (they ran $265M, then $250M, then $230M, despite the 50%-of-FCF policy); or KGC lagging its peers by more than 3 points without explanation. Upgrade toward Buy only on a clean print plus a daily SuperTrend flip and a visible step-up in buybacks.

Price target: $24.70, a valuation objective. I took the midpoint of the bear EPS ($2.42) and consensus ($2.78), which is $2.60, and applied 9.5x, between today's 8x and the 10-11x recovery range and below August's ~12x. That gives $24.70, about +11% from 22.24. Cross-checks: 10x on $2.42 is $24.20; 9x on $2.78 is $25.02; the Bollinger mid-band is 24.88; the daily SuperTrend is 25.27. The downside tail is 8x on $2.42 ($19.36) or 7x on $2.42 ($16.94, about -24%), which is why sizing stays small.

Missing data that lowers confidence: spot gold (~$4,107) comes from a single unverified source; Q3 average gold versus Q2, realized prices, AISC and royalties are absent; the timing and size of the guidance cut are unconfirmed; the date of the consensus figure and the gold price behind it are unknown; the 10-year yield is missing because the FRED pull failed; the FOMC date (believed 27-28 Oct) is unconfirmed; today's bar may be provisional; the cause of today's 5% gap is unexplained; and the MFI scale is unverified.

Current Price: 22.24

Price Target: 24.7

Confidence: Low

Time Horizon: 6-12 months